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MAGIC BULLET:
THE HISTORY OF ORAL REHYDRATION THERAPY
by
JOSHUA NALIBOW RUXIN *
In February 1994, the directors of major United Nations agencies, the Prime Minister of
Bangladesh, medical researchers, international health advocates andpoliticians gathered in
Dacca, Bangladesh, to celebrate the twenty-fifth anniversary of a life-saving technique
known as oral rehydration therapy (ORT). UNICEF and the International Centre for
Diarrhoeal Disease Research organized the meeting in order to recognize those who
originally developed and promoted the therapy and to refocus attention on the continued
underutilization of ORT throughout the world.'
More than two decades earlier, in Dacca, East Pakistan, and Calcutta, India, many ofthe
people who attended the meeting, along with others, had developed the use of an
extraordinarily simple solution consisting of sugar, salts, and water to save the lives of
severely dehydrated adults, children, and infants.2 These researchers, some of whom had
not yet completed their medical residencies, were affiliated with powerful U.S. institutions
including Johns Hopkins, Harvard, the Centers for Disease Control, the U.S. Navy, and the
National Institutes for Health. In 1962 they began work on effective therapies for
cholera-induced diarrhoea which was claiming thousands oflives globally during seasonal
epidemics. Within six years, these men produced and synthesized physiological evidence
tha4t overturned the medical establishment's paradigm for diarrhoeal treatment. Through
determination, intuition, and serendipity, they developed a new therapy which proved
effective in clinical trials. Before its promotion worldwide in the late 1970s, the majority of
people with diarrhoeal dehydration had no access to effective treatment. ORT can be
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utilized effectively in even the most isolated parts ofthe world and today saves the lives of
over one million children annually.3
Every year, in every developing country, diarrhoea has been one ofthe leading causes of
childhood death.4 Since ORT requires only sugar, salts, and water mixed in proper
proportions, it might be expected that some person would have discovered it-or at least a
crudeequivalent-long ago. However, although somecultures and societies developed oral
therapies believed to be effective, no one remedy ever gained global acceptance. Rather,
most cultures developed local therapies ranging from coconut milk to emetics.
The simplicity of ORT contrasts starkly with the story ofits discovery which overflows
with abrasive personalities, professionaljealousies, and scientific breakthroughs, as well as
with an unusual degree of scientific co-operation. An analysis of the pertinent scientific
papers alone fails to convey adequately the story ofORT and suggests that its development
was a smooth, linear progression of innovations. However, in the eyes of many of its
greatest advocates and contributors, the development itself constitutes a scientific
revolution. The history ofORT reveals an extraordinarily long path to discovery followed
by an ongoing struggle for legitimacy and implementation. When examined in historical
context, the account lends itselfto discussion ofmany ofthe themes which perplex medical
historians: the conflicts between "high" and "low" technology, between labor-atory and
clinical science, and between public health and medical research. Furthermore, it
demonstrates how the prejudices of the medical establishment and its reverence for
advanced technology can postpone life-saving discoveries.
Despite the significance ofORT, the story of its discovery, like other twentieth-century
public health accomplishments, has remained largely untold.5 A few of the researchers
involved have written their accounts in short articles for specialized conferences on ORT
and scientific journals. These publications, however, fall short of defining the context in
which the discovery was made and fail to cover all the events associated with it. The only
book that extensively addresses the subject, Cholera: the American scientific experience
1947-1980, written by W. E. van Heyningen and John R. Seal, lacks historical analysis,
focuses on cholera, and contains numerous factual errors.6 Moreover, the views presented
are coloured by Seal's involvement with ORT, thereby producing a biased presentation.
Fortunately, most ofthe researchers involved in the development ofORT remain alive and
active today. This narrative relies on a series of personal interviews and correspondence
Norbert Hirschhorn and William B. Greenough III, 'Progress in oral rehydration therapy', Scientific
American, 1991, 264 (5): 50-6. See also, UNICEF, The state ofthe world's children 1994, Oxford University
Press, 1993, p. 6.
4 UNICEF, op. cit., note 3 above, p. 6.
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of smallpox, officially completed in 1979. In an earlier paper I investigated the media's coverage ofthe smallpox
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6 W. E. van Heyningen and John R. Seal, Cholera: the American scientific erperience. 1947-1980, Boulder,
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with more than a dozen of the most significant figures. The majority of their insights,
perceptions, and anecdotes are previously undocumented. Based on these interviews and
scientific publications, this paper first establishes a framework for understanding the state
ofdiarrhoeal physiology and therapy before work in Dacca and Calcutta began in 1962. It
then turns specifically to Dacca and traces the developmental research preceding the
execution of the first clinical trial of a practical oral therapy in 1968. Next, it briefly
follows the spread of the therapy's use from Dacca and Calcutta to the rest of the
developing world, before turning finally to examine the uneven path to the acceptance of
oral therapy.
DIARRHOEA: THE GLOBAL KILLER
During the late 1970s world health experts estimated that the approximately 500 million
annual episodes of diarrhoea in children under the age of five resulted in at least five
million deaths per year.7 These generally occurred in the developing world where one in
ten children died of diarrhoea before the age of five.8 Although these statistics are recent,
the tragedy they reflect is not exclusively a modern phenomenon. Sanskrit literature and the
Hippocratic corpus contain discussions about the scourge of diarrhoea and its treatment.9
While healers continued to discuss diarrhoea during the following centuries, they made
little progress toward understanding its causes or developing a widely available treatment.
Diarrhoea is not a disease; it is a symptom whose aetiology includes food poisoning,
bacterial and other microbial infections, and it can be deadly. The dehydration it causes
can quickly destroy the ability of a body to function. Children under the age of five are
especially susceptible to diarrhoea, and in severe cases their mortality rate often exceeds
50 per cent. The condition is most harmful to young children since they daily exchange
more than one half of their extracellular fluid in the gut compared to one seventh
exchanged by adults."' If this fluid exchange is impaired, a child becomes dehydrated
much more quickly than an adult. When diarrhoea strikes a child, the body begins to expel
essential electrolytes and water. This depletion may quickly lead to dehydration. The
characteristics of choleraic dehydration, which differ little from the dehydration of other
aetiologies, are well known to doctors in the developing world. According to one
physician the dehydration manifests itself in the following manner,
The eyes and the cheeks are sunken, the face is pinched, the lips and the tongue are dry, the
fingertips are shriveled ("washerwoman's hands"), and the voice is hoarse ... Ifthe skin is
pinched, especially over the abdomen, the skin folds do not disappear for some time ...
The pulse pressure decreases and it becomes imperceptible on the radial arteries ... The
7 'Control of diarrhoeal diseases: WHO's programme takes shape', WHO Chronicle, 1978, 32 (10): 369-72,
on p. 369.
x Robert L. Parker, Ward Rinehart, Phyllis T. Piotrow, and Louise Doucette, 'Oral rehydration therapy (ORT)
for childhood diarrhea', Population Reports, January 1985, 12 (4): p. L-41.
' Susruta, an ancient Indian medical figure and the father of Ayurvedic medicine (( . 1500 BCE), prescribed that
diarrhoea victims should be "given to drink a profuse quantity of tepid water in which rock salt and molasses
have been dissolved; or clarified water combined with rice gruel", Susruta Samhita 111, verse II. See also, Dr
William B. Greenough 111, interview, 5 February 1992, transcript p. 8, and Harris L. Smith MD, 'Historical notes
on parenteral fluid therapy of diarrhea in infants,', J Pediatr., October 1960, 57 (4): 611-16, on p. 611.
"' Leroy J. Stephens, MD, and William E. Henrickson, 'Mild diarrhea in children', Mo. Med.-J. Missouri State
Medl. Ass., 1954, 51 (2): pp. 105-6.
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urine diminishes in quantity .. Muscle cramps, principally of the extremities but also of
the trunk, are common at this stage ... In fatal instances, death often ensues on the second
or third day of the disease. . .
The sight and plight ofpatients in this condition encouraged researchers to find better ways
of treating diarrhoeal dehydration, but despite extensive experimentation, it was not until
the mid 1920s that a relatively effective and safe treatment emerged. This entailed
rehydration with expensive hospital-administered intravenous solutions. Although
efficacious, it was essentially unavailable to the people most plagued by diarrhoea, those in
the developing world.
Theprevalence ofcholera in the developing world inspired many scientists to search fora
therapy that could be utilized in the field, far away from hospitals and the technologically
advanced intravenous treatment. William B. Greenough III, aphysician who was intimately
involved with the study of cholera and worked for several years in Dacca, has pointed out
that intravenous treatment was totally inadequate forcholeracases in the field: "I've been in
the field with five thousand cases ofcholera when the only thing you could do was ... drag
people who were infected into the middle ofthe field so that they would not infect everyone
else. So it was obvious that without some breakthrough ... you were not going to make a
dent in cholera."'2
THE SEARCH FOR AN EFFECTIVE TREATMENT
In western medicine most scientific research on diarrhoea during the first half of the
twentieth century can be divided into two categories. There were those researchers who
studied the various aetiologies ofdiarrhoea and conceived ofantibiotic treatments asacure.
They often subordinated practical issues of dehydration treatment and concentrated their
efforts on the pathogen because they believed that the most effective therapies for
diarrhoeal diseases could be found only when the causes were known.'3 Other researchers
concentrated on finding a solution that could consistently rehydrate children without
complications. Some of these people favoured various isotonic electrolyte solutions for
diarrhoeal treatment. This categorization, however, should not suggest that there were two
separate groups; in fact, many researchers concerned themselves with all aspects of
diarrhoeal disease.
Those who searched for a universal cure for diarrhoea often advocated solutions
concocted from carob flour, bananas, orother substances. In 1950, PerSelander, a Swedish
doctor, championed the use of carrot soup at a time when some American doctors were
publicizing the attributes ofcarob flour and dehydrated bananas. '4 According to Selander,
"Carrot soup is an extremely reliable, easily obtainable, and simple, nourishing substance
" Oscar Felsenfeld, The cholera problem, St Louis, Missouri, Warren H. Green, Inc., 1967, pp. 59-60.
12 William B. Greenough III, interview, 5 February 1992, transcript p. 3.
3Milton Feig, 'Diarrhea, dysentery, food poisoning, and gastroenteritis',Am. J. Publ. Health, November 1950,
40 (11): 1372-94.
14 Joseph H. Fries, NicholasJ.Chiara,and RobertJ. Waldron, 'Dehydrated bananainthedietetic managementof
diarrheas of infancy', J. Pediatr., 1950, 37 (3): 367-72, on p. 367. See also Alan E. Smith and Carl C. Fischer,
'The use of carob flour in the treatment of diarrhea in infants and children', J. Pediaitr., 1949, 35 (5): 422-6, on
p. 422. William Z. Fradkin, 'The dietary treatment ofdiarrheal diseases', Am. J. Digestive Disorders, July 1953,
pp. 208-10.
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which acts promptly in the treatment ofacute diarrhoeal disturbances in infants. In my own
experience, I have found carrot soup to be far superior to all substances hitherto
employed."'5 Regardless of effectiveness, diarrhoeal treatments like Selander's reflected
the lack of information doctors then had about the physiological mechanisms ofdiarrhoea.
The developers of these treatments therefore gauged their success on a case-by-case basis:
how many patients improved and how quickly. They did not explain why, they improved.
Nevertheless, these eccentric therapies often produced outwardly impressive results
while utilizing methodologies now considered archaic. In a 1950 study that useddehydrated
banana, the average time of complete recovery from dehydration in infants who received
the treatment was 2.9 days, in sharp contrast to 5.02 days for the control group receiving
routine hospital therapy.'6 Fruit and vegetable therapies were always oral, whereas most
others remained intravenous. Doctors found that intravenous solutions worked well and
provided them with precise control over the treatment, while oral solutions appeared
scientifically unsound.
The composition of intravenous solutions changed with increased metabolic research
during the 1940s and 1950s, yet, despite this, the basic treatment protocol remained the
same. The therapy involved the parenteral administration of electrolyte solutions, blood
transfusions, fasting, and the gradual commencement of feeding at the end of the
"starvation" period. 1 This fasting was a crucial element of most diarrhoeal therapies and
was based on the pervasive beliefs that the gastrointestinal tract required an opportunity to
rest and recover and that oral intake aggravated diarrhoea since the diarrhoeic gut could not
absorb fluids.'8 With therapies ofthis sort, infants often needed to stay in hospital for one to
two weeks in order to recover.'9 These lengthy stays can partly be attributed to the
malnourishing effect of the treatments on the patients. Even with these therapies, public
health physicians worried about infant diarrhoeal epidemics in nurseries which "frequently
develop[edl a high case fatality rate with attendant unfavorable publicity".2(0 These high
death rates highlight the overall ineffectiveness of the treatments then available; diarrhoea
still posed a major public health threat to young children.
DANIEL DARROW AND THE COMPOSITION OF DIARRHOEA
At the heart of ineffective diarrhoeal therapies was a lack of knowledge about the
electrolytes expelled and how best to replenish them. During the 1940s Dr Daniel Darrow of
Yale University began ground-breaking electrolyte studies that reverberated through the
scientific community; at the same time much work was being done on the physical
processes in the body that diarrhoea interrupts and alters.2' Darrow began advocating
rehydration solutions that included potassium, sodium chloride, and glucose based on
s Per Selander, 'Carrot soup in the treatmnent of infantile diarrhea', J. Pedaitr., 1950, 36 (6): 742-5, on p. 743.
'"Fries, Chiara, and Waldron, op. cit., note 14 above.
Harold E. Harrison, 'The treatment ofdiarrhea in infancy', Pediaitr. Cliii. North Ant., Symposium on Clinical
Advances, May 1954, pp. 335-48, on p. 338. Parenteral treatment refers to any solution that is injected into the
body. Most commonly it indicates an intravenous (IV) injection.
Ix Carl A. Holmes, 'Diarrhea with dehydration in infants', Arizona(i Medicine, 1955, 12 (5): 195-6, on p. 196.
"' Ibid., p. 195.
D. Crosby Greene and Robert M. Albrecht, 'Recent developments in diarrhea of the newborn', NY State J.
Med., 1955, 55 (1): 2764-8, on p. 2764.
' Smith, op. cit., note 9 above, p. 614.
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soundphysiological observations and principles.22 The opening statement in his significant
1949 article well reflects his focus: "Effective replacement of water and electrolyte in
patients with diarrhoea should be based on exact knowledge ofchanges in composition of
body fluids."23 He believed that one could not blindly treat diarrhoeal dehydration without
understanding what the body was losing. Consequently, his studies described which
electrolytes are lost in an episode of diarrhoea and in what quantities they should be
introduced back into the body. Although he did not champion an oral therapy over
parenteral treatment, he concluded that an oral solution ofpotassium, lactate, and glucose
could help restore lost water and electrolytes and thereby avoid "prolonged parenteral
therapy".24 Darrow's intravenous and oral treatment brought the case fatality rate ofbabies
with moderate to severe dehydration below 5 percent.25 Eighteen years laterthis method of
limited parenteral therapy followed by an oral electrolyte and glucose solution, with some
refinements and a new physiological paradigm, would be known as oral rehydration
therapy. Darrow laid the foundation for future research by recognizing that treatment, at
leastintheclinical stages, couldnotconsistofaguessinggame toascertain which vegetable
formula or solution worked best.
Scientists involved in the discovery of ORT disagree on the importance of his
contribution. Greenough believes that Darrow developed good rational therapeutic
solutions, especially one which could be parenterally administered. Although it was
important that Darrow drew scientific attention to the repair of electrolyte deficits in
children, Greenough asserts that "he did not have any of the information which allowed
them [oral solutions] totakeoffafter 1967 or 1968".26 DrNorbert Hirschhom, whoplayed a
major role in the development of ORT, agrees with Greenough, but gives more credit to
Darrow for having pinpointed which electrolytes needed replenishing. Hirschhorn points
out that before Darrow, rehydration solutions "had been quite empiric-sometimes they
threw a lot of salt in, sometimes a lot of bicarbonate or lactate in it'".27 In all rehydration
therapies there was inadequate correlation between what the body lost and what doctors
reintroduced into the patient.
Darrow's work seemed all the more significant since children were particularly at risk
from debilitating or fatal dehydration due to the lack of physiological knowledge and its
reflection in various products. For example, infant formulas and over-the-counter oral
rehydration solutions contained far too much sugar and salt, a potentially lethal
combination which aggravated diarrhoea.28 When a person ingests a solution with a higher
concentration of sugar or salt than the body, water osmotically leaves the body and enters
the intestinal lumen (in an attempt to maintain isotonicity), andthis results indehydration as
well as higher salt concentrations in the body.29 Concentrated sugar and salt solutions
employed in the 1950s were born of a lack ofknowledge ofcertain biological mechanisms
22 Daniel Darrow, et at., 'Disturbances of water and electrolytes in infantile diarrhea', J. Pediatr., 1949, 3:
129-56.
23 Ibid., p. 129.
24 Ibid., p. 151.
2- Ibid., p. 152.
26 Greenough, interview, 5 February 1992, transcript p. 8.
27 Dr Norbert Hirschhorn, interview, 10 January 1992, transcript p. 1.
2x Greenough, interview, 10 January 1992, transcript p. 8.
29 This clinical state is referred to as hypernatremia.
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combined with recognition ofthe efficacy of some solutions.30 It is not surprising that the
majority ofphysicians heldfasttotheparenteral route since only afew voicesinthe medical
community affirmed that some oral electrolyte solutions, at least in mildcases ofdiarrhoea,
were as efficacious as the intravenous route.
Although Darrow may have produced some effective parenteral and oral therapies, his
premise for oral rehydration highlights why his studies did not lead directly to modem day
ORT.32 He and otherdoctors at the time viewed oral treatments, at best, as an intermediate
step between intravenous therapy and feeding. As Hirschhom explains, oral rehydration
for Darrow was not "a way ofreplacing intravenous fluids or a way ofproviding fluids to a
population that would not have intravenous fluids".33 Unlike the Dacca and Calcutta
investigators, Darrow was not exposed to the need for a simple oral solution.
GLUCOSE, SODIUM, AND WATER TRANSPORT
The practical applications of physiological findings in the 1950s remained limited to
parenteral therapy and rarely, ifever, pointed toward an oral therapy. In 1953 R. B. Fisher
and D. S. Parsons, sugar physiologists at the University ofOxford, discovered part of the
mechanism for glucose transport across the excised small intestinal wall of the rat.
Although scientists had previously assumed that many cells were permeable to glucose in
the small intestine, Fisherand Parsons found that glucose appeared to be transported across
the intestine by only a few cells; the others were impermeable to it.34 They therefore
concluded that there might be specific receptor sites for glucose-a crucial component for
theeventual understanding ofrehydration therapy. However, researchers atthe time did not
recognize that, ifglucose were to be a part of a rehydration solution, the function ofthese
receptor sites should not be impaired.
There was no obvious link between Fisher's and Parsons' work and a rehydration
solution. Fisher and Parsons were strictly physiologists: they made no mention of
rehydration solutions and experimented only in vitro. Lacking evidence to the contrary,
electrolyte physiologists believed that glucose absorption was paralysed during diarrhoea,
and clinicians therefore advocated resting the bowel. The misconception, which seemed
plausible at the time, was that any solution which entered the gastrointestinal track during
diarrhoea, particularly choleraic diarrhoea, would be expelled.
The work of Fisher and Parsons furthered Darrow's research and inspired extensive
studies of electrolyte transport in the intestinal tract. Their work was not immediately
applied practically since past findings had not been replicable in vivo. Following in their
footsteps, the physiologists Riklis andQuastel published the results ofan important in vitro
work on sugar absorption in 1958. They were the first to demonstrate that the active
absorption ofglucose inexcisedguineapig intestine isdependenton thepresenceofsodium
ions. They also began to find the concentrations for optimal water, sodium, and glucose
"'Greenough, interview, 16 December 1991. See also, Eleanor Colle, et al., 'Hypertonic dehydration
(hypernatremia): the role of feedings high in solutes', Pediatrics, 1958, 22(5): 55-12.
3' Stephens and Henrickson, op. cit., note 10 above.
32 See Daniel C. Darrow and John S. Welsh, 'Recent experience in the treatment of diarrhea in infants', J.
Pediaitr., 1960, 56 (2): 204-10.
33 Hirschhorn, interview, 10 January 1992, transcript p. 1.
3'- R. B. Fisher and D. S. Parsons, 'Glucose movements across the wall of the rat small intestine', J. Phsiol-.,
1953, 119: 210-23.
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absorption.35 Riklis and Quastel inspired another sugar physiologist, Robert Crane, to
define the mechanism for the active transport of glucose in the presence of sodium.36 All
these studies ultimately helped in the understanding, if not the development, of ORT since
they illustrated the coupling of glucose and sodium, the therapy's major constituents. This
type of research would later be relevant when the effective and relatively safe
concentrations of modern oral therapy were being determined.37
Most acute watery diarrhoeal diseases, such as cholera, do not destroy the mucosal
membrane ofthe small intestine, although they may alter it.38 While diarrhoea results from
an increase in the net fluid output from the intestine which in turn leads to dehydration, the
absorption of fluid may continue-the problem lies with the net output. One could try to
rehydrate by drinking lots of water, but would still lose water and expel much more salt.
This is where ORT and the glucose and sodium chloride mechanism are relevant. When
glucose is added to the mucosal membrane (where it is absorbed by the sites R. B. Fisher
proposed), sodium chloride intake is greatly increased along with glucose and water. Even
if the person continues to expel considerable amounts of fluid, the glucose allows the
absorption of more fluid than is being expelled. Diarrhoea may continue, but the
dehydration will be corrected.39
With the close of the 1950s, a new force in physiology emerged at the Harvard
Biophysics laboratory. There, Drs Curran, Zalusky and Schultz furthered the work of
earlier physiologists and concentrated on links between sugar and salt absorption.4" Dr
Michael Field, who worked in the laboratory during the time of Schultz, Curran, and
Zalusky, contends that their work "showed two things: one is that sodium dependence of
sugar absorption really means that sugar and sodium are absorbed together, that is that
their movement is coupled on a particular transport protein ... and then they showed it
also to be true for amino acids".4' It was the sugar and sodium co-transport mechanism
which Schultz and Curran elegantly documented that was the cornerstone of their work.42
Schultz and Curran's work had broad implications for electrolyte physiologists. When
Darrow put glucose in his rehydration solutions during the late 1940s, he did so in part
because he thought that it contributed calories to the patient's system. Schultz and Curran
demonstrated that the function of glucose in solution was "entirely independent of
" E. Riklis and J. H. Quastel, 'Effects of cations on sugar absorption by isolated surviving guinea pig
intestine', Catnt. J. Biochem. PhYsiol., 1958, 36 (3): 347-62.
3' Robert K. Crane, 'Hypothesis for mechanism of intestinal active transport of sugars', Federaitioni
Proceedings, November-December 1962, 21: 891-5. Dr Michael Field, interview, 19 February 1992, transcript
p. 2. See also Dr Stanley G. Schultz, interview, 24 February 1992, transcript p. 4.
3 Although oral therapy studies frequently cited Crane, they rarely, if ever, mentioned researchers such as
Riklis and Quastel.
3' Dr R. B. Sack, written comments, September 1993. Dilip Mahalanabis, interview and personal
communications, August 1993. Also David Nalin, personal communication, April 1994. Dysenteries, for
example, do damage the membrane.
39 Richard Cash MD, 'A history of the development of ORT', S'nmposiunm Proceedings. Cereail-Baised Orail
Rehvdration Therapy: theorv and practice, 17 February 1987, pp. I } 105.
Dr Field, interview, 19 February 1992, transcript p. 2.
4 Ibid. Field asserts that Schultz and Curran "were the centres ofthat s sugar and sodium physiology work".
42 Stanley G. Schultz, Robert E. Fuisz, and Peter F. Curran, 'Amino acid and sugar transport in rabbit ileum', J.
Gen. Ph.'siol., 1966, 49: 849-66. See also, Peter F. Curran, 'Sodium, chloride, and water transport by rat ileum in
vitro', J. Genl. Ph!.siol., 1960, 43: 1137-48.
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metabolic pathways" and was not to provide energy.43 Like the otherphysiological studies
discussed, the findings of Schultz and Curran pertained to the normal physiology of the
gut, they were not intended for application to diarrhoeal treatment.
By the 1960s, physiological knowledge of fluids reflected the dualistic approach of
physiologists to their work. They recognized the inadequacies of their findings, while, at
the same time, anticipating major breakthroughs. Perhaps the words ofDr Harris L. Smith
best exemplify this: "Only the foundations," he wrote, "have been laid for our
understanding of the basic physiology of cells and their environment. Undoubtedly a
multitude of exciting discoveries awaits physicians, investigators, and practitioners alike,
in the realm of body fluid dynamics and in their application to diagnosis and therapy."44
Months later, after rigorous comparisons of the available parenteral therapies, Smith's
optimism plummeted, and he conceded that "the gaps in our understanding of the
physiology of body fluid, both in health and in disease, have thus far precluded the
formulation ofa completely ideal regimen ofparenteral fluid therapy for severe diarrhoea
in infants".45 The decade began without a manageable oral therapy or a widely-practised
effective parenteral therapy.
CAPTAIN PHILLIPS' CHIOLERA TREATMENT
In September 1961, a cholera pandemic broke out in the Philippines. At that time, Dr
Robert A. Phillips, whose cholera-related work dated back to 1947, sent a team from
NAMRU-2 (Naval Medical Research Unit) in Taipei, Taiwan, to treat patients at San
Lazaro hospital in Manila. Using Phillips' parenteral cholera treatment, which he had
improved over the years, the hospital maintained a low mortality rate of 3.4 per cent.
Lieutenant Commander Craig Wallace managed the operation of the treatment centre.46
When cholera returned in the summer of 1962, Phillips and his colleague Wallace picked
up where some of Phillips' previous physiological studies had left off and began further
experimentation on cholera patients. For two patients, Phillips added glucose to electrolyte
solutions taken by mouth.47 He was astounded to find that the addition tremendously
enhanced sodium absorption-the same observation that several physiologists such as
Crane, Schultz and Curran had already made in vitro using healthy animal gut. Unlike his
predecessors, Phillips utilized a diarrhoeal model.
According to some researchers familiar with Phillips and his work, Phillips sought a
solution that contained less sodium electrolyte but remained isosmolar; he wanted a
non-electrolyte to replace some of the sodium in the solution and the non-electrolyte on
the shelf was glucose. These researchers further assert that Phillips chose glucose only to
maintain the molarity of the solution; his decision was independent of the physiological
studies that had shown that it could augment absorption in non-diarrhoeal in vitro
preparations.48 Had Phillips been guided by Schultz's and Curran's work, history might
4' Hirschhorn, interview, 10 January 1992, transcript p. 2.
44 Smith, op. cit., note 9 above, p. 614.
4' Harris L. Smith and James N. Etteldorf, 'Parenteral fluid regimens in the treatment of severe diarrhea in
infants', J. Pediatr., 1961, 58 (1): 1-16, on p. 14.
4' Dr Craig K. Wallace, personal communication, April 1994.
47 Van Heyningen and Seal, op. cit., note 6 above, pp. 72, 228-30.
4X DrDavid Nalin, interview, 14February 1992,transcript p. 3. SeealsoCash,op.cit., note 39above, p. I I. Cash
claims that Phillips was unaware ofthe co-transport studies conducted by Riklis and Quastel, as well as those by
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display a smooth and tidy scientific progression of discoveries from in vitro physiological
observations to clinical application.49 The record on this point, however, is anything but
neat.
Regardless of the influences, Phillips' work first demonstrated that oral therapy could
be viable. Today, most ORT researchers praise Phillips for his finding. They believe that it
was doubly important since it furthered studies carried out only in animal models, and it
contradicted the conventional wisdom of the time which required that the gut be starved in
all diarrhoeal treatment. Phillips had shown that cholera patients might be able to drink
their therapy. This was the first discovery of a rational scientifically-based oral therapy for
cholera patients.
Spurred on by this success, Phillips excitedly extrapolated his observation to a clinical
trial. On 4 August 1962, his team in Manila, led by Wallace, treated three patients with a
potent oral electrolyte solution containing high concentrations ofglucose and sodium and
achieved good results. Phillips then instructed Wallace to set up a large clinical trial for
this solution, to be carried out in September when Phillips would be away. Of the thirty
patients involved in the study, five died.5" Since the oral solutions were three times
isotonic concentration, and intravenous fluids were co-administered, fluid overload
resulted and this led to congestive heart failure.5'
Their deaths may also have occurred because, as one researcher maintains, the clinical
trial was carried out under conditions which were inferior to a standard trial since
"Phillips wanted a method to approximate actual physical facilities then present in much
of the world".52 Phillips did not prescribe standard patient monitoring because he wanted
even a young child to be able to carry out the treatment.53 Given the nature of a potential
panacea for diarrhoea, he recognized that it would have to be utilizable under terrible
conditions; his experiment attempted to replicate these and confirm the treatment. Perhaps
Phillips believed that he was on the verge of discovering a magic bullet for dehydration
caused by cholera. Accordingly, he held a press conference before sending Wallace off to
carry out the clinical trial. He reportedly stated that he and his colleagues were on the
verge of discovering an oral cure for cholera.54 This public optimism probably made the
failure immensely more painful. The experimental methodology Phillips used was
Schultz and Curran. See also van Heyningen and Seal, op. cit., note 6 above, pp. 229-30. Dr Graham Bull, who
analysed the data with Phillips, agrees with Cash's assessment, while other physicians disagree with this
perspective. Dr Charles C. J. Carpenter visited Phillips and Wallace soon after the experiment and asserts that the
co-transport work of Schultz and Curran inspired Wallace and Phillips to introduce glucose into the solution. Dr
Charles C. J. Carpenter, interview, 27 February 1992, transcript p. 2. Although Seal implies that Wallace would
agree with Carpenter's view, today Wallace asserts that the choice of glucose was "more than serendipity .. lit
wasI an educated guess". He states that the physiological work of Schultz, Curran and others did not provide the
impetus. Rather, that glucose was one of a few non-electrolytes of' choice in related physiological studies.
Wallace, personal communication, April 1994.
4 Nalin notes, however, that there was not truly abridge between in *itro work (like that of Schultz and Curran)
and in v'iio work. These types of research were like "night and day" and a major leap of faith would have been
needed to apply a principle demonstrated only in healthy excised animal tissue to a human diarrhoeal patient.
Nalin, personal communication, 8 April 1992.
5" Wallace relates that, of the five who died, a few were compromised patients already suffering from
tuberculosis and other diseases. Wallace, personal communication, April 1994.
5' Van Heyningen and Seal, op. cit., note 6 above, pp. 231-3.
12 Cash, op. cit., note 48 above, p. 11.
13 Remark by Craig Wallace in van Heyningen and Seal, op. cit., note 6 above, p. 232.
5 Van Heyningen and Seal, op. cit., note 6 above, p. 231.
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weakened not only by his search for a magic bullet, but also by a faulty scientific
hypothesis. According tQ Hirschhorn, Phillips and his colleagues worked on the premise
that the intestinal sodium pump had been poisoned by cholera.55 The purpose of the
so-called "cholera cocktail" was therefore to "unpoison the pump".56
The deaths that resulted had major repercussions for Phillips and his colleagues.
According to a visitor at the Naval Research Center in the Philippines during the autumn
of 1962, soon after the tragedy, Wallace "felt badly about it", and Phillips "felt so badly
about it he didn't pursue it any further".57 These emotions even led Phillips to conceal the
deaths and to delay publishing the other results, including his distinguished verification of
glucose-sodium absorption in vivo, until 1964.
Phillips' 1964 paper explicitly cites the hypothesis of the poisoned sodium pump and,
moreover, does not cite any of the sugar-sodium physiologists who had theorized
glucose-sodium coupled transport.58 This void further demonstrates that Phillips was
ostensibly uninspired by such physiological work and perhaps ignorant of it. His failure to
mention the physiologists also suggests that their in vitro studies in non-diarrhoeal models
were not the likely route to a diarrhoeal therapy given the attitudes of the day.59 Most
significantly, Phillips reported that with glucose and sodium solutions (such as the ones he
used in August 1962) the rate of sodium depletion decreased and glucose was absorbed,
and he stated, for the first time, that the function of the glucose transport mechanism was
apparently unimpaired in cholera.6"' Some ofthe important observations Phillips presented
could have been supported by current physiological research; had he correlated such work
with his own, he might have been on the verge of discovering oral therapy. By the same
token, he could not have carried out his fatal experiment since he would have recognized
that no acceptable physiological hypothesis supported his concentrated solution.
Moreover, had he promptly published his results, more progress on oral therapy might
have been made by other investigators.
Clearly concerned with his failure, Phillips expressed extreme caution in the conclusion
of the 1964 paper, writing that an oral regimen "can only be validated by careful balance
studies".6' It was the lack of such studies during the experiments in the Philippines that
resulted in the five deaths. Despite this tragedy, Phillips expressed cautious optimism for
the future oforal solutions, "one may be able to develop an oral treatment regimen which
in the average case might completely eliminate the requirement for intravenous fluids".62
5 See R. A. Phillips, 'Water and electrolyte losses in cholera', Federatio)7 Proceedinigs, 1964, 23: 705-12.
Sb Hirschhorn, interview, lOJanuary 1992, transcript p.3. Dr Henry Mosley, who later worked veryclosely with
Phillips in Dacca, East Pakistan, alleges that Phillips' belief was that the oral rehydration cocktail "would reverse
the fluid loss and that the patient would absorb their own water, so to speak, back into the intestine with the salt
and sugar". Mosley, interview, 25 February 1992, transcript p. 2.
7 Carpenter, interview, 21 February 1992, transcript p. 1.
s Phillips, op. cit., note 55 above, p. 709. Among the work Phillips might have cited was research by Crane,
Riklis and Quastel, Schultz and Curran, and Fisher and Parsons.
59 Not only did Phillips neglect to mention physiological work about the coupling of glucose and salt, he
presented an alternative explanation for his observation of Na+ and Cl- ions being absorbed with water and
glucose. This further fortifies the earlier suggestion that the work ot the sugar physiologists had not led Phillips to
choose glucose for his solution. See note 47 and Phillips, op. cit., note 55 above, p. 712.
"" Phillips, op. cit., note 55 above, p. 712. Importantly, Phillips also showed that bicarbonate and potassium were
aibsorbable in cholera patients even without the presence ot glucose.
6'Ibid.
`2 Ihid.
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Thus, although the mode of practical implementation of a glucose-sodium solution had
been an overall failure, even Phillips recognized that his work outlined the possibility for
an effective therapy. While he saw the potential for oral therapy, he could not and would
not overcome his shock from the Philippines. In the four ensuing years oral therapy
research was significantly slowed down and even threatened by Phillips' trauma.
DIARRHOEAL TREATMENT IN THE EARLY 1960s
By the mid-1960s, Phillips was not the only supporter of careful balance studies with
fluid therapies. Other doctors were acutely aware that fluid therapy, if improperly
administered, could do more harm than good. An article published in 1964 mentioned that
incorrectly administered therapy could result in death.63 In spite ofthis danger, the authors
proceeded to state that children could be given oral therapy to supplement intravenous
therapy and eventually work their way into oral maintenance therapy without intravenous
solution. Consequently, it appears that doctors continued to view oral therapy as the
transition between parenteral therapy and feeding for which Darrow had designed it. Two
other U.S. physicians that year wrote that "There can never be an exact answer to this
question [of glucose-salt proportionsi for the particular patient to be treated, nor is there
any laboratory test that can be done easily and quickly enough to provide an answer to this
question in a clinical situation".64 Therefore, despite their advocacy of a therapy
consisting ofsodium chloride and glucose, they did not believe that there existed one ideal
rehydration solution. Given the unique circumstances of each patient, there could be no
specific formula. Clearly, the concept of oral rehydration was in the air, but its precise
form evaded discovery.
THE CHOLERA RESEARCH LABORATORY
In December 1960, the Pakistan-SEATO Cholera Research Laboratory opened in
Dacca, East Pakistan.65 During its first two years, the laboratory produced very little
substantial work. By 1962, some individuals at the National Institutes for Health, which
funded the laboratory in part, had learned of Phillips' work in the Philippines and
recognized the potential for creating an oral therapy. Prior to leaving for Dacca in 1962,
Greenough, a cholera physiologist, discussed oral rehydration with Dr Joseph Smadel,
who worked under the director of NIH. According to Greenough, Smadel told him "that
there was a possibility from the Navy work [Phillips' work in the Philippines] that one
could treat cholera patients with oral rehydration solutions". The suggestion left
Greenough rather miffed because "having at that point read something about cholera and
the amount of fluid losses I thought that that loral rehydration] was quite an outlandish
idea".66 This encounter with Smadel reflects the paradoxical mental framework under
"3 Lewis A. Barness, MD, and Leighton N. Young, MD, 'A simplified view ot fluid therapy', Pedlitr. Cliii.
North Am71., 1964, 2 (I): 3-15, p. 3. Nevertheless, public hea,lth workers in Mexico and Venezuela were
increasingly using glucose-sodium oral solutions. See A. Yankauer and N. K. Ordway, 'Combbating diarrhoeal
disease in Latin Amlerica', WHO (hroniicle, 1964, 18 (7): 260-4, on pp. 262, 264.
61 Saul W. Bruislow, MD, and Robert E. Cooke, MD, 'Fluid therapy ot diarrhea and vomiting, Pedli(itr. Cliii.
North Al., 1964, 11 (4): 89-9901, on p. 890.
61 SEATOp)roceeding.voft/ic ('t f cron we o lholerai, December 1960, Do(ccl, East Patikstioi, Bangkok,The Post
Publishing Co. Ltd., 1962.
""Greenough, interview, It) January 1992, transcript p. 1.
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which cholera researchers operated at the time. On the one hand, they "recognized that
intravenous hydration was not a solution to the problems in the field 'cause it was too
restrictive and expensive to use in the situation where cholera occurred" and therefore
worked toward a non-intravenous therapy. On the other hand, most researchers readily
admit that even the concept of an oral therapy through the late 1960s "was quite
unbelievable to most people".67
When Greenough arrived at the laboratory, untreated villagers with cholera had a 30 to
40 per cent mortality rate. As at that time the only cholera treatment considered acceptable
was intravenous therapy, the researchers at the laboratory were developing ways to treat
large numbers of people in the field with it.68 Given the morbid situation, Greenough and
the others concentrated on improving the parenteral therapy and on finding ways to
shorten the duration of the cholera. They therefore closely monitored the fluid intake and
output of the patients and attempted to implement and modify Phillips' parenteral solution
that had maintained such impressively low mortality rates in past cholera epidemics.
Within one year Greenough and the staff had brought the mortality rate in the hospital
down to under I per cent.6'9 With the cholera situation under control, the laboratory could
then begin to expand its efforts and investigate the physiology of cholera and electrolyte
transport in the gut. At that time, the leadership of the laboratory recruited Dr Hirschhom
and others to go to Dacca.7"
When Hirschhorn arrived, Greenough and his colleagues were studying the defects in
the epithelial transport system that cholera impaired. Initially, Hirschhorn concentrated on
the relationship between cholera and intestinal enzymes.7' Soon after, Phillips came to
take command of the Cholera Research Laboratory. His experience in the Philippines still
weighed heavily on him and therefore he "had a very conservative view about continuing
any human research on oral rehydration therapy".72 Nevertheless, the interest of his staff
in oral rehydration was very high although they still viewed it principally as an
intermediate step between parenteral therapy and feeding.73 Moreover, they believed it
would be a potential treatment for adult cholera patients only. According to Hirschhom,
"Nobody thought about this [oral rehydration] for children and for diarrhoea other than
cholera leven] in 1965 and 1966".7 Unlike scientists in the United States and Europe, the
researchers at the Cholera Research Laboratory had a narrow conception of diarrhoea, for
them it usually signified cholera.
Another important figure in the discovery of ORT, Dr David B. Sachar, arrived in
Dacca in 1965. Sachar contends that at the time "the prevailing theory was that the
secretory diarrhoea of cholera represented paralysis of the sodium pump".75 Essentially,
67 Ibid.. p. 3.
(xIbid., p. 1.
Greenough, personail comimillunication. I I March 1992
7 Greenough, interview, 5 Februairy 1992, transcript p. 2.
7' Ibid., p. 3.
72 Mosley, interview, 25 Februairy 1992, transcript p. 2
7 The stafts zittitude mirrors Darrow's view of oral rehydration fromii over a decade earlier. The researchers'
concern for oral therapy suggests that while their rationale and physiological knowledge pointed toward it only as
zin intermediate treattment, they intuitively felt that it could serve ai greater purpose.
7' Hirschhorn, interview, 10 January 1992, transcript p. 3.
75 Dr David Sachar, interview, 29 February 1992, trianscript p. 2.
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cholera treatment ideology had not changed since Phillips' studies in late 1962. The
clinical director of NIH at that time, Dr Robert Gordon, was very interested in verifying
Phillips' hypothesis of the poisoned sodium pump. In the words of Sachar, he believed
"that ifthere were a way to measure the electric potential inside the lumen ofthe intestine,
that the theory of sodium pump paralysis could be supported by finding a loss of the
normal negative potential". Gordon assigned the task to Sachar, who, with the help of
Phillips, went to Copenhagen to design an experimental apparatus with a friend ofPhillips,
the distinguished physiologist, H. H. Ussing.76
They were successful, and Sacharreturned to Dacca in March 1966 with an apparatus.77
An article by the British physiologists R. J. C. Barry and D. H. Smyth, which had shown
that an actively transported sugar in a rabbit increased the negative potential across the
gut, inspired Sachar to test his system similarly. It would be the first time this experiment
had been carried out on a human sick with cholera.78 Sachar did not know of any
therapeutic implications that the observations of Barry and Smyth might have for cholera,
he wished to show only that the test he had designed would work. During the autumn of
1966 the experiment succeeded in showing an increase in negative potential, and Sachar
and his associates "were really thrilled, dancing around the test lab".79 However, the group
was excited only because the apparatus had worked. Its implications were not immediately
apparent.
THE FALL OF THE POISONED SODIUM PUMP HYPOTHESIS
Soon after the experiment, Sachar and his colleagues collaborated with Hirschhom and
recognized that they had disproved the paralysed sodium pump hypothesis; they had made
a breakthrough in physiology relevant to cholera-induced dehydration.8tt In one sense,
Sachar's Dacca work had not accomplished anything revolutionary. It did not define a new
physiological mechanism, it simply demonstrated that an already defined mechanism
worked in humans sick with cholera as well as in animals. The article describing the
experiment stated that "The diarrhoea in this disease [cholera] is, therefore produced by a
mechanism which does not substantially alter the normal intestinal transmural electric
potential, and the intestinal capacity for sugar-dependent sodium transport probably
remains intact"8. Phillips had originally believed that cholera patients should be treated
with his oral sugar-electrolyte cocktail after he observed enhanced sodium absorption. The
poisoned sodium pump hypothesis guided Phillips' experimental trial and tragedy.
Sachar's work brought cholera research right back to where Phillips had been four years
76 Ibid., p. 2.
77 Priortoarriving in Dacca in 1965, Sacharhad met Schultz and Zalusky at the Harvard Biophysics laboratory,
who helped him "understand a little better how enhanced glucose-linked sodium absorption would be reflected in
an increased transmural electric potential". In spite of this Harvard connection, Sachar does not cite this
interaction as having been a crucial influence on his experiment. Ibid., p. 3.
7X Schultz, etal. haddemonstrated that theelectric potential would rise inanimals, the very same workthat Barry
and Smyth had done. Ibid., p. 3.
79 Ibid., p. 2.
xo Ibid., p. 2. The significance ofthe increased electrical potential was that it was a "reflection ofthe enhanced
active sodium transport out of the lumen into the circulation". Ibid., p. 3.
81 David B. Sachar, James 0. Taylor, J. R. Saha, R. A. Phillips, 'Intestinal transmural electric potential and its
response to glucose in acute and convalescent cholera', Gastroenterologv, 1969, 56 (3): 512-21, on p. 512.
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earlier, before the cocktail was used.82 The researchers in Dacca now knew of two points
crucial for oral therapy: first, that glucose probably improved sodium and water absortion
in cholera patients, and, second, that the paralysed pump hypothesis was false. Sachar's
demonstration had immediate positive implications for cholera research.
HIRSCHHORN TAKES CHARGE
When Hirschhorn saw the initial results of Sachar's experiment, he quickly perceived
the link to Phillips' earlier work in the Philippines.83 He told Sachar that he wanted to
move forward immediately to a clinical test in order to confirm that net positive fluid
balance could be achieved with glucose and sodium solutions. Sachar felt that Hirschhorn
was far too impatient and that such a trial would be "premature".84 So Hirschhorn had to
"fight" both Sachar and Phillips in order to run his therapeutic application.85 Hirschhom
himselfadds temporal and practical factors to his race for a clinical trial; he asserts that in
the autumn of 1966 the laboratory was running low on intravenous fluids, the number of
cholera patients was increasing, and they therefore had no choice but to move ahead with
oral therapy-related studies.86
While Sachar hesitantly accepted Hirschhom's appeal, Phillips posed a much greater
block to the process. He had, for all intents and purposes, instituted a moratorium on all
experimentation which related to oral therapy. Hirschhom asserts that it was only when it
appeared that the laboratory would have to come up with an alternative therapy that
Phillips allowed the work to continue, and only ifHirschhorn proceeded cautiously.87 The
study which he carried out was similar to Phillips' 1962 disaster except that this time the
process was based on proven physiological principles. The solution was isotonic and the
patients were monitored with advanced laboratory equipment. Eight cholera cases were
admitted to the study, all of whom were in shock upon admission. The study utilized two
approaches to perfusing fluid. Six of the patients received the electrolyte fluid
intragastrically while the others received intestinal perfusions through multi-luminal
tubing. The researchers maintained intravenous fluids throughout treatment and perfused
52 The influence of Phillips, at least in the medical literature, was often explicitly stated. Sachar noted in this
article that "the therapeutic implications ofthis hypothesis Ithat the sodium pump remains intact in cholera] were
first proposed by Phillips". Ibid., p. 519.
13 Seal relates a dramatic story in which Phillips, after discussing Hirschhorn's proposed trial, locked the door
and showed Hirschhorn the results of the fatal trial in the Philippines (van Heyningen and Seal, op. cit., note 6
above, p. 234). Phillips' secrecy slowed oral therapy research by blocking experimentation and the
communication ofpertinent information as well. Hirschhorn states that he saw the notes from Manila in October
or November of 1966-virtually at the same time as Sachar's work. Hirschhorn, personal communication, II
April 1994.
x Sachar, interview, 29 February 1992, transcript p. 2. It is remarkable that van Heyningen and Seal neglect to
mention the early work of Sachar. According to them, the revelation of the work in Manila alone inspired
Hirschhorn to pursue his research. Moreover, they imply that it was Hirschhorn's work that had encouraged
Sachar. This inaccurate presentation of events detracts from the impressive sequential chronology of the studies
in Dacca. See van Heyningen and Seal, op. cit., note 6 above, pp. 234-6.
15 Sachar, ibid., p. 8.
8" Hirschhorn, interview, 10 January 1992, transcript p. 3.
X7 Ibid., pp. 3-4. Hirschhorn's viewpoint suggests that Phillips foresaw some type of practical therapy being
born out of this experiment. Nalin contests this point and asserts that Hirschhorn was able to move forward
only by premising the study on its physiological, not its practical, basis. Nalin, interview, 14 February 1992,
transcript p. 4.
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one litre ofsolution per hourregardless ofoutput.88 The solution, therefore, was not meant
as a practical therapy that could be introduced in the field, since the patients had tubes in
their stomachs and intestinal tracts; the researchers set out to lay the groundwork for oral
therapy.
The results of Hirschhom's study, carried out between November 1966 and March
1967, showed that a glucose solution always lowered the net stool output (indicating net
absorption) and that a solution without glucose invariably increased it.89 Effectively, the
study confirmed the work that Phillips had done in 1962 and published in 1964.9" The
researchers cautiously concluded that "oral glucose therapy could be of value in the
treatment of cholera and that the requirement for expensive and scarce intravenous fluids
may be reduced thereby".9' They limited their conclusion to cholera since they could not
imagine using such a treatment on otherpatients. People were dying from cholera in far off
areas, where intravenous treatment could not be supplied, and they wanted a therapy for
them. Although Hirschhorn recognized some of the practical applications that Sachar's
work and the follow-up had suggested, he could not foresee its major implications.
At this point, however, there were physicians who saw the full potential oforal therapy.
At a presentation of Hirschhom's findings in Dacca, one of the plantation doctors, Dr
Mackay, responded ecstatically.
He [Dr Mackay] got up and said "This is one of the most profound developments in the
treatment of . .. cholera diarrhoea this century". And I remember being a little startled by
that and saying to myself . . "gosh, maybe he's right". But we had come at it [cholera] in
terms of this [being] a really amazing scientific finding and it was based on true
physiology .., we were also preparing ourselves for using it as an emergency measure
when we ran out ofIV fluids. We were not yet saying that this would be a great thing to put
into a village. It seemed like this was something we could use as an emergency backup.92
Perhaps it is due to such experiences that Hirschhorn asserts that his balance studies, along
with the work which demonstrated that cholera allowed co-transport to function, signified
the point at which the physiological basis for oral therapy had been discovered.93
Even after the successful study of decreased stool output, Hirschhorn remained
pessimistic about the future of oral therapy research, partly because he paid meticulous
attention to every indicator, and this intensive analysis made him question whether there
would ever be a practical basis for oral therapy.94 Hirschhorn believed that he had
X Norbert Hirschhorn, Joseph L. Kinzie, David B. Sachar, Robert S. Northrup, James 0. Taylor, S. Zafar
Ahmad, and Robert A. Philips, 'Decrease in net stool output in cholera during intestinal perfusion with glucose-
containing solutions', N. Engl. J. Med., 25 July 1968, 176-81, on pp. 176-7. The title of this article and others
related to this topic could deceive readers unfamiliar with the experimentation since they imply that the stool
output decreased with intake of glucose-sodium solutions. In fact, the stool output might increase as more
solution is ingested. The crucial point is that the net amount, the solution ingested subtracted by the stool plus any
vomitus, was positive. Thus, although there may have been more fluid expelled from the body than before
treatment, overall the intestines absorbed more than was lost.
`9 Ibid.
" Nalin, interview, 14 February 1992, transcript p. 3.
9' Hirschhorn, et al., op. cit., note 88 above, p. 176.
9 Hirschhorn, 10 January 1992, transcript p. 6.
9 Ibid., p. 8.
9 Ibid., p. 4.
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completed the groundwork for it, but that the therapy still did not exist as a distinct entity
and might never be feasible. One researcher suggests that the use of nasogastric and
multiluminal tubes in Hirschhorn's experiment severely limited even consideration of its
practical potential.95 The members of the research team used these tubes to make precise
physiological observations and because they did not believe that a patient could drink the
quantities needed for adequate rehydration. Although the physiological basis for oral
rehydration had been demonstrated, the composition of a practical therapeutic regimen
remained elusive.
PROGRESS IN CALCUTTA
Hirschhorn was not alone in his balance studies in 1967. The Johns Hopkins Center for
Medical Research and Training in Calcutta, which had been established at roughly the
same time as the Cholera Research Laboratory in Dacca, was working on similar issues.
While some say the relationship between the laboratories was friendly, recently the two
groups have vied for credit, especially in the area of oral rehydration therapy.96 The
Calcutta group visited Dacca and observed Hirschhom's work. Ledby Nathaniel F. Pierce,
they substantially improved the experimental design and conducted a study between May
and July 1967.97 The Indian Journal ofMedical Research published their findings two
months before Hirschhom's appeared in print.98
Although the study by Pierce and others contained conclusions that mirrored those of
Hirschhom, a close comparison of the apparatuses reveals the substantial improvements
made by the Johns Hopkins Center. All the glucose solutions were perfused
intragastrically at a rate which exceeded stool output by 100 to 200 ml per hour, whereas
Hirschhom's procedure had prescribed one litre per hour regardless of output.99
Additionally, Pierce and his team systematically varied the glucose-sodium ratios, thereby
providing important knowledge about effective glucose levels. Furthermore, the Calcutta
study stopped supplemental intravenous therapy on some ofthe patients, indicating greater
confidence in the effectiveness ofthe glucose solution, and thereby being the first to show
that cholera patients could be hydrated (for at least twelve hours) by an intragastric
glucose solution alone.") Essentially, the Calcutta experiment advanced Hirschhom's
Mosley, interview, 25 February 1992, transcript p. 2.
"" However, unlike the stereotypical cutthroat competition of today, the two laboratories freely shared their
results.
Nathaniel F. Pierce, personal correspondence, 20 April 1994.
x Pierce states that researchers were widely discussing glucose-sodium solution to rehydrate cholera patients
during the summer of 1966 and that it was then that he decided to carry out an experiment. Ironically, he, like
Hirschhorn, suggested the idea to Phillips and received an unenthusiastic response. Nathaniel F. Pierce, personal
correspondence, 16 November 1993.
9' The Calcutta study did not use the impractical multi-liminal tubing Hirschhorn had utilized.
I' N. F. Pierce, et il., 'Oral maintenance of water-electrolyte and acid-base balance in cholera: a preliminary
report', 1nl. I.. Jinied. Res., 1968, 56 (5): 640-5. See also, Nathaniel F. Pierce, et ld., 'Effect of intragastric
glucose-electrolyte infusion upon water and electrolyte balance in Asiatic cholera', Gastroeniterology, 1968, 55
(3): 333-43. Nathaniel F. Pierce, personal correspondence, 16 November 1993. Some dispute the chronology
of the experiments. Dr Charles C. J. Carpenter explicitly stated in reference to Hirschhorn's experiments that
"They Ithe Cholera Research Laboratoryl did parallel studies shortly after Dr Pierce did them". Carpenter,
interview, 21 February 1992, transcript p. 2. In a separate interview, on the same topic, Carpenter said, "I think
that the study that Bert Hirschhorn did at Dacca was done virtually simultaneously with the ones they did in
Calcutta; and they were both very important. I think that Nate's [Pierce's was a little more meticulous; he had a
better set-up and the sense to do it, I don't think any particular additional credit derives to him for doing it first".
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framework and made an important contribution to the feasibility of an oral glucose
solution. The conclusions reached by both groups were reinforced tremendously by their
independently concordant results. Their work demonstrated that Phillips' observation had
not been an anomaly and carried the promise for a practical oral rehydration therapy a
great step ahead.'0'
With the scientific groundwork laid for ORT, one might expect that a practical therapy,
or at least experiments on oral therapy would have followed immediately. On the contrary,
oral rehydration-related work slowed because the researchers had to wait for the next
cholera season. According to Henry Mosley, the chiefepidemiologist in Dacca at the time,
Phillips felt that the research questions had been answered and that therefore, the Dacca
team's work with oral therapy had been completed.'02 Hirschhorn attributes Phillips'
"change of heart" to the kinship bonds he felt for those doctors with whom he worked.
After his experiment and a trip to the United States, Hirschhorn had intended to return to
Dacca, but his visa was not approved.'03 Phillips, who had confidence in him, "didn't
quite trust the next crew that came along",104 and with Hirschhorn absent from the
laboratory, much of the inspiration for progress toward an oral therapy faded.
THE REINS ARE PASSED
The crew that arrived in August 1967 consisted of Drs Richard Cash and David Nalin.
At the time, Nalin, twenty-six years of age, had completed only the first year of his
medical residency when the international research office at the National Institutes of
Health assigned him to Dacca. Nalin was told only that he would be working on clinical
research on cholera.'05 Cash, also twenty-six, had just finished his internship in surgery
and had become a U.S. Public Health Service Officer. The National Institute for Allergies
and Infectious Disease assigned him to Dacca. Neither doctor had had any previous
experience with cholera or epidemic diarrhoea.'06
There was some continuity between the old guard at the laboratory and the new. Before
arriving in Dacca, Nalin and Cash heard Hirschhorn and Pierce present their findings at a
cholera symposium in Palo Alto, California, in July 1967. Hirschhorn's study came under
the heading 'Pathophysiologic studies in man and in animals' rather than a title which
which might have suggested a practical component of the work.'07 Nalin's and Cash's
reactions were that the physiological work and the possibility for oral therapy were
"interesting" but unfeasible.""' Nalin felt that there was "absolutely no one who believed
that an oral therapy could work as a practical thing in rural areas or even in hospitals". In
Thus, although Carpenter generally suggests that the studies occurred at the same time, he incorrectly believes
that Pierce completed the trial first. Carpenter, interview, 27 February 1992, transcript p. 3.
"" In Cholera van Heyningen and Seal fail todifferentiate between Hirschhorn's study and Pierce's. They imply
that the work progressed independently and produced identical conclusions. Op. cit., note 6 above, pp. 236-7.
102 Mosley, interview, 25 February 1992, transcript p. 2.
'3 Hirschhorn, interview, 10 January 1992, transcript p. 6.
"4 Ibid., p. 4.
'") Nalin, interview, 14 February 1992, transcript p. 1.
")6 Nalin and Cash were required to serve in some governmental capacity because ofthe Vietnam War. Cash,
personal communication, I April 1992.
107 'Symposium on cholera', Palo Alto, California, July 26-28, 1967 (unpublished document). Pierce and his
associates referred to their study as oral maintenance.
"' Nalin, interview, 14 February 1992, transcript p. 2.
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physical terms alone he could not comprehend how a patient in shock could possibly drink
one litre of oral rehydration therapy per hour for twenty-four hours, especially without
modern equipment and medical personnel.'09
THE CHITTAGONG PROTOCOL
In late September 1967 cholera broke out in the Chittagong district of East Pakistan,
along the Burmese border. Dr Olson, the Director of the Christian Mission Hospital in
Malumghat, requested assistance from the laboratory."'l1 Nalin and Cash travelled to the
site to help establish a clinic for the victims and to carry out studies of their own. At
roughly the same time, Dr James Taylor, a senior investigator at the laboratory, asked Dr
Rafiqul Islam, a young, local investigatorfrom the laboratory, to write a short oral therapy
protocol. When the treatment centre was established, Kendrick Hare, the director of the
Cholera Research Laboratory under Phillips, and Ruth Hare, the head ofthe biochemistry
laboratory, assigned Nalin to oversee Islam's protocol.'"' Although Phillips was out ofthe
country for at least part of the time when the protocol was executed, Nalin concedes that,
despite Phillips' "cold feet" on oral therapy, "he was willing to test the waters [with this
protocol]".'12 None the less, Nalin asserts that Phillips "probably thought that he would
never let it [the protocol] get developed to a full practical extent"."3 The manner in which
this protocol had come into existence supports this assertion. Rafiqul Islam believes that
his designation as author, along with other local, less experienced investigators, indicated
the weak commitment to oral rehydration therapy by the Cholera Research Laboratory.' 14
The protocol which Islam and others executed between October and November 1967
failed to demonstrate the efficacy of an oral therapy. Although there were no deaths, most
ofthe patients became overhydrated or remained dehydrated on the treatment. There was
one major flaw in the formula ofthe protocol; it called for one litre ofthe glucose therapy
to be given intragastrically to patients every hour (for the first eight hours) regardless of
output data.' ' A patient who excreted 250 millilitres per hour was therefore given the
same amount of rehydration fluid as a patient who excreted 1,250 millilitres per hour. The
protocol distinctly paralleled the study by Phillips in the Philippines where data regarding
intake and output were also overlooked and did not correlate to the treatment.
The underlying feature that Phillips' Philippine study shared with this failed protocol
was that both searched for a magic bullet for choleraic dehydration. The investigators who
"" Ibid.
Dr Rafiqul Islam, personal correspondence, 23 August 1993.
Nalin, personal communication, 2 April 1992. Also Islam, personal correspondence, 23 August 1993. While
the designation of Nalin to oversee the protocol intimates a substantial commitment on the part ofthe laboratory
to practical oral therapy, Nalin was totally unfamiliar with cholera and diarrhoea at the time. Thus, he was one of
the weakest chioices. Others at the laboratory were carrying out highly advanced metabolic studies and would
have been more suitable to analyse and manage the protocol.
112 Nalin, interview, 14 February 1992, transcript p. 11.
"'3 Ibid. There was atechnical advisory committee, consisting ofhigh-ranking officials from NIH and the CDC,
which wanted further work to be carried out on oral therapy. The development of this first protocol appears to
have been a token gesture to placate the interest of the staff in practical experimentation.
114 Nalin's supervisory role of the protocol written by Islam was meant to be peripheral. Islam, personal
correspondence, 23 August 1993, and personal communication, 24 August 1993.
' Dr Rafiqul Islam and P-SCRL Ward Physicians, 'Research protocol: oral lavage of a solution containing
glucose, electrolytes and tetracycline as a method of treatment in acute cholera', unpublished document, in notes
of Paki.stan-SEATO Cholerai Research Laboraitor-y Technical Committee ineeting 27-29 November, 1967.
381Joshua Nalibow Ruxin
designed the studies believed that the oral solution would have to function in terrible,
primitive conditions and would therefore have to consist of one universal form and
quantity."6 The Chittagong protocol demonstrates that the authors could not conceive of
untrained villagers or public health workers knowing how much solution to give the
cholera patients. They therefore decided on an arbitrary amount, one litre, and hoped for
success. Likewise, Hirschhorn's study involved perfusing the glucose solution at the rate
of one litre per hour, regardless of net output.'17 This similarity suggests that the work
completed by Hirschhorn was the basis for the protocol. Islam recalls writing the protocol
under the guidance of Taylor and using Hirschhom's and Phillips' earlier work as the
"basic guidelines".' 18 Thus Islam and the other investigators mistook Hirschhorn's purely
physiological study for a practical one. Hirschhorn had set out to clarify and confirm the
1962 findings of Phillips; he did not create a practical treatment. "9 Had Islam and the
others used the latest study by Pierce as the basis for the protocol, it is likely that the
experiment would have been a success.
Upon the failure of the Chittagong protocol, Nalin had the opportunity to analyse the
results. After looking at the findings, he did not simply label oral therapy as unusable.
Had he done so, it might have been many months or even acouple years before researchers
developed an effective oral rehydration regimen. Nalin remembers "sitting in a tent and
going over the data from the failed ... study and ... very clearly suddenly realizing that
this had to work and also having the feeling that it was very important to make it work".121)
He asserts that he realized precisely what went wrong with the Chittagong study and
understood that if the dosage of the therapy corresponded to intake and output
measurements then it would be "a sure fire success". 21 Having spent months in thejungle
where intravenous therapy could not be used efficiently oreffectively, he recognized "how
important this would be for these people [in thejungle]"..'22 Nalin and Cash returned to
Dacca in December 1967, determined to carry out a revised clinical trial based on Nalin's
new, second protocol.123 They knew, however, that they would have to wait a few months
for the spring cholera outbreak.
THE SECOND PROTOCOL
In Dacca, Phillips learned of the failed protocol and then responded with great
pessimism to Nalin's and Cash's desire to forge ahead. While Phillips evidently did not
"16 Nalin, interview, 4 February 1992, p. 4.
'17 Hirschhorn et cil., op. cit., note 88 above, p. 176.
118 Islam, personal correspondence, 23 August 1993.
'' According to Sachar, the study with Hirschhorn was impractical because "Wedidn'tdevelop that protocol as
an optimal therapeutic regimen; it wasjust a metabolic study, to determine a yes-or-no phenomenon, to shift the
patient from negative balance to positive balance. And the logical way to do that, when you're doing a metabolic
study, as opposed to making up a treatment protocol, is to use a fixed dose", Sachar, interview, 29 February 1992,
transcript p. 7.
1'21 Nalin, interview, 14 February 1992, transcript p. 5.
121 'Ibid. Nalin relates that an important newchange made in hisprotocol was to matchoral solution volume tothe
volume ofdiarrhoea plus vomitus ofthe previous four or six hour period. This ensured maintenance of water and
electrolyte balance. Nalin, written comments, April 1994.
122 Nalin, interview, 14 February 1992, transcript p. 5.
2T Islam states that Nalin ignored "me and my other national colleagues . . Being local young researchers, we
could not raise our voice against expatriate's decision". Islam, personal correspondence, 23 August 1993.
Nevertheless, Islam would later be listed as a co-author of Nalin's protocol.
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stop the new protocol from being carried out, it was executed only when he had left the
country on a trip. The Cholera Research Laboratory policy dictated that in Phillips'
absence, the deputy director, Kendrick Hare, would be acting director, and he
enthusiastically allowed the second protocol a clinical trial. It can be conjectured that he
consulted Phillips beforehand, and, since they were old friends, Phillips approved it.
Whatever the case, Nalin, Cash, Islam, Molla (another local investigator), nursing
supervisor Torrance, and nurses Bashonti, Gomes, Gafur, and Margaret executed the
second protocol in the Cholera Research Laboratory hospital in Dacca.'24 The protocol
signified the first time a glucose maintenance solution had been given by mouth since
Phillips' failed protocol six years earlier. The researchers utilized every available
safeguard; additionally, Cash or Nalin was always right next door in case problems
arose.125 In an effort to demonstrate the effectiveness ofthe therapy in the most severely ill
patients, the researchers accepted only patients who arrived in a state of shock.'26 They
then gave them just enough intravenous therapy to achieve a stable pulse rate and begin
oral treatment. Nalin was the driving force for the exclusive use of oral therapy in the
experiment.'27 Islam recalls "When we saw a patient, we hesitated just to allow the
patients on oral therapy alone ... unless we started IV we feared the patients' deaths.
Nalin had a stronger belief [in the therapy] than [we did]. The other local doctors and I had
hesitation ... [Nalin] was reluctant [to restart IV] when, after initial IV hydration, output
increased and we [the local doctors and nurses] wanted to restart IV".128 Nalin's
perseverance resulted in unparalleled success. Forthe first time, aglucose-sodium solution
alone, given only by mouth, maintained water and electrolyte balance during cholera.
After treating several patients, all the researchers recognized they had been successful;
they had reduced the usage ofintravenous solutions by 80 per cent, even in these critically
ill patients.129
Nalin and Cash treated the first patients in this study during April 1968 and the Lancet
published the results in August. In the article they concluded that "an oral solution
''4 Dr Abdul Majid Molla, personal correspondence, 23 August 1993.
5 Nalin, interview, 14 February 1992, transcript p. 6. David Nalin, 'Clinical trial ofan oral therapeutic solution
t'or acute cholera in adults', unpublished document. In this trial protocol the oral infusion rate depends on net
stool output and vomitus; it is not a fixed rate as in the unsuccessful protocol. Not only was Cash's or Nalin's
presence necessary in case of an emergency, but also to ensure scientific accuracy. The other doctors and nurses
who monitored the patients did not trust the oral solution and sometimes turned on the intravenous drip for
patients who were taking it withoutjustification related to hydration status. Nalin, written comments, April 1994.
'"' Generally, those patients whohad nodeterminable pulse in theirradial artery were considered tobe in shock.
They generally required IV therapy equivalent to 10 per cent of body weight at the time of admission. Nalin,
written comments, April 1994.
1'' This therapy cannot accurately be labelled oral rehydration therapy since IV therapy rehydrated the patients.
The oral glucose solution maintained their hydration status and should therefore be referred to as oral
mlaintena(nllce therapy.
_'x Islam, personal interview, 24 August 1993.
'2' Nalin's protocol called for4.22grams ofNaCI, .5 grain ofKCI, 4 grams ofNaHCO , and 20gramsofglucose
mixed in one litre of water. The WHO's official formula today is based on the formula used in Calcutta and
consists of 3.5 grams NaCI, 1.5 grams KCI, 2.5 gramis NaHCO3, and 20 grams ofglucose dissolved in one litre of
water. Van Heyningen and Seal allocated two sentences to Nalin's revision and neglected to mention the
breakthrough fromil orogastric tubes to oral administration. Thus the first practical ORT trial is poorly
documented in their book-according to the text, no significant breakthrough was made in April 1968. Op .cit.,
note 6 above. pp. 237-8.
383Joshua Nalibow Ruxin
containing glucose and electrolytes can eliminate the need for over three-quarters of the
intravenous-fluid requirement in the therapy of acute cholera in adults". However, they
stopped short of advocating their therapy in all situations, claiming that although "mild
cases of cholera [without shock] may be treated with oral solution alone", "specially
trained staff' were still needed to oversee patients being treated with oral therapy.'30 Oral
therapy worked, but it had only been proved effective in a meticulously controlled and
monitored environment; the next step was to demonstrate its usefulness in the rural areas
of East Pakistan where intravenous therapy was unavailable.
While oral therapy research moved forward, its proven utility caused the previously
fairly subtle competition between the Dacca and Calcutta cholera laboratories to surface.
After finishing the report for the second protocol, Nalin travelled to the Johns Hopkins
research laboratory in Calcutta to share notes.'3' Although the John Hopkins staff had
advanced Hirschhorn's work a year earlier, they had not made the same progress as Nalin
and Cash.'32 Nalin claims "they greeted my news [of the second protocol] initially very
hostilely and said it was reckless and irresponsible and would never be practical".'33 Nalin
does not attribute their reaction to jealousies or indifference, rather, he believes that the
group in Calcutta was familiar with Phillips' failure and had been influenced by the
"folklore" surrounding cholera. For example, since vomiting was a characteristic of the
first few hours ofthe disease, these researchers could not imagine patients swallowing and
holding down so much fluid.'34 One month after Nalin's visit, Cash visited Calcutta and
found the group carrying out an oral therapy protocol that utilized nasogastric tubing and
tested the efficacy of a glucose-electrolyte solution. Then, at a conference in Teheran in
August, Pierce approached Nalin and Cash and asked them whether they would be
interested in co-publishing their results; Nalin replied that the results had already been
published in the Lancet, and Pierce expressed disappointment.'135
While there has been some disagreement about whether Calcutta's or Dacca's oral
therapy study came first, the evidence overwhelmingly supports Dacca. Kendrick Hare
sent Nalin's study in to the Lancet on 25 June 1968, and the editor approved it for
publication on 2 July 1968.'137 Pierce's publication of his oral therapy experiment was
131 David R. Nalin, Richard A. Cash, Rafiqul Islam, Majid Molla, Robert A. Phillips, 'Oral maintenance
therapy for cholera in adults', Lancet, 1968 ii: 370-3, on pp. 37(-2.
3 David Nalin, 'Dr. David Nalin's visit toJohns HopkinsCMRT,Calcutta', unpublished document, 13-7 May
1968.
132 Nalin does, however, point out that Nate Pierce had unsuccessfully tried another solution which substituted
maltose for glucose. Nalin, interview, 14 February 1992, transcript p. 7.
33 Ibid.
134 Ibid.
35 Pierce, personal correspondence, 20April 1994. According toNalin andCash, Pierce becameagitated on this
occasion and made critical remarks. Nalin, interview, 14 February 1992, transcript p. 8, and Cash, personal
communication, February 1992.
3' The only person I encountered who challenged the chronology ofNalin's and Cash's work was Charles C. J.
Carpenter, who was in close contact with the Calcutta laboratory and was head of it in the early 1960s. With
regard to the first trial he states, "I don't know when he [Nalini got there, so I can't corroborate anything about
that, but I certainly do want to say that he doesn't seem accurate lin calling his the firstl." Carpenter's words
seem especially misleading since Pierce agrees with Nalin's chronology. Pierce, interview, 31 March 1992, and
27 February 1992, p. 2. See also note 100 above.
1'7 Kendrick Hare, letter to the editor of the 1Lncet (unpublished document), 25 June 1968. Also, 1.
Douglas-Wilson, letter to David R. Nalin, unpublished document, 8 July 1968.
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based on work executed between May and July 1968 and expressed conclusions similar to
those of Nalin and Cash.'38 Pierce began the study only after Nalin's visit in mid-May
1968.139 He affirms that "It would be unrealistic to state that the information provided by
Dr Nalin during his visit did not affect our decision [to pursue glucose-based oral
therapy]". He further emphasizes the importance of his work having confirmed that of
Dacca.'40 It must be noted, however, that the cholera seasons heavily influenced the
timing ofstudies in both places. In Calcutta the season lasts from May to September, while
in Dacca it spans November to February, often with a small outbreak in the spring.'4'
Considering this, the linearity of the experimentation is astounding. Sachar's spring 1966
study led to Hirschhorn's winter 1966 work which Pierce advanced in the summerof 1967.
Inspired by Hirschhorn, Islam proceeded with the Chittagong protocol in the winter of
1967 which Nalin transformed into oral therapy during a spring outbreak in 1968. Pierce
then confirmed Nalin's work in the summer of 1968. Thus, researchers in Calcutta and
Dacca carried out substantive studies during every cholera season from 1966 through
1968.
Although Phillips was out of the country during the time of the second protocol, Nalin
included his name on the study since he believed "that his earlier work justified it".'42
When Phillips returned from his European trip, the entire laboratory was enthusiastically
supporting their work. Although they had achieved success, Nalin and Cash realized that,
without a trial which used the therapy in the field, the scientific community at large would
remain unconvinced. They therefore began planning for a field trial of their oral therapy
without requesting the help of Islam or Molla.143 Phillips openly discouraged their plans.
Nalin speculates that Phillips, under the influence of his alcoholism, might have been
dwelling on the tragic outcomes in the Philippines.'44 Mosley disagrees and asserts that
Phillips simply did not see Nalin's and Cash's proposal for a field trial as "real
research". 45 Additionally, Mosley states that Phillips might have worried that his clinical
R Nathaniel F. Pierce, R. Bradley Sack, Rupak C. Mitra, John G. Banwell, Kenneth L. Brigham, David S.
Fedson, Arabindo Mondal, 'Replacement ofwater and electrolyte losses in cholera by an oral glucose-electrolyte
solution', Annl. Internt. Medl., June 1969, received December 1968, 70 (5): 1173-81.
'-" Van Heyningen and Seal present Carpenter's ambiguous version ofthe story. They state that when Pierce
took over the laboratory in 1966, he began testing oral glucose-electrolyte solution, which leads the reader to
believe that there was an oral therapy in 1966 and that it was first developed in Calcutta. This recapitulation of
the story conveys a misunderstanding about the meaning of oral rehydration. For example, van Heyningen and
Seal call the replication by Calcutta ofHirschhorn's work oral rehydration when, in fact, it was a metabolic study
which did not constitute a practical therapy. Op. cit., note 6 above, pp. 236, 240.
14' Pierce, personal correspondence, 20 April 1994, and personal interview (recorded), 31 March 1992. It is
crucial to recognize that the study by Pierce had been planned between September 1967 and March 1968-before
Nalin's visit and possibly before Nalin wrote the second protocol. However, the study as planned and conducted
still used nasogastric tubes-it was not precisely a practical oral therapy. This supports the assertion by Pierce
that Nalin only encouraged Calcutta to switch to a glucose-based oral therapy study. Pierce does not believe that
"it INalin's visit] affected the design of the trial we carried out" (emphasis mine). Furthermore, Pierce recalls
that, by Nalin's arrival, the maltose study already appeared inferior to IV therapy. He states, "we lin Calcuttal
were aware that he INalinI and Dr Cash had completed an important clinical trial based on the previous year's
studies and we wanted to make every effort to complete at least one trial of our own during the 1968 season".
Pierce, personal correspondence, 20 April 1994.
41 Nathaniel F. Pierce, personal correspondence, 16 November 1993.
142 Nalin, interview, 14 February 1992, transcript p. 12.
43 Islam, personal interview, 24 August 1993, also Molla, personal correspondence, 23 August 1993.
144 Nalin, interview, 14 February 1992, transcript p. 12.
'45 Mosley, interview, 25 February 1992, transcript p. 3.
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researchers would be distracted from "making new discoveries" if they focused their
efforts on practical applications. The data had convinced Phillips that oral therapy worked,
but most people, including himself, still did not fully recognize its significance.'46
MATLAB
In the autumn of 1968, Nalin and Cash wrote an oral rehydration therapy protocol to be
carried out in the field, in Matlab Bazaar, rural East Pakistan. They aimed to carry out the
trial not only to prove the effectiveness of their therapy, but also to best treat the epidemic
in Matlab. In Matlab there would be a limited supply of intravenous solutions and there
would be patients who, without oral rehydration therapy, might have no treatment
whatsoever. Phillips responded negatively to their proposal and told them that they would
not be permitted to execute it. Given the impending situation in Matlab, Nalin and Cash
felt that they were encountering "irrational fears". Moreover, no one had given them a full
account of the circumstances surrounding the five deaths in the Philippines, a lack of
communication which certainly increased the mysteriousness of Phillips' negativity.
Finding Phillips to be totally intractable and having heard of a telegram from the
National Institutes of Health that research should not continue, Nalin, Cash, and their
supporters at the laboratory began discussing alternatives. One option was to ignore their
orders and proceed with the study. However, they swiftly concluded that as Public Health
Service Officers, they could thereby be subject to court martial.'47 With this punishment
and Phillips' attitude in mind, Nalin and Cash turned to Henry Mosley, the head of
epidemiology at the Cholera Re.search Laboratory, for help.
Due to a previous arrangement, Mosley functioned autonomously at the Cholera
Research Laboratory, and only had to obtain project approval from the Centers for Disease
Control (CDC) and his superior at the Epidemiological Intelligence Service, Alex
Langmuir.'48 Mosley told Phillips that he wanted Nalin's and Cash's Matlab protocol
performed. Mosley asserts that Phillips had no problems with the plan, provided that Nalin
and Cash did not work on the project full time, and that his only reservation about the
project initially had been that he did not want his clinical researchers working on practical
field trials instead of research. Mosley wanted Nalin and Cash to play a major role in the
trial since "they had been involved intimately with the development of the protocol ...
and they were the ones that would be most capable of managing the project".'49 Mosley
therefore resolved initially to have two Epidemiological Intelligence Service officers sent
to Dacca through the CDC. These doctors, under the direction of Nalin and Cash, would
carry out the protocol in Matlab. Langmuir readily agreed to the plan, and Phillips
expressed no further objection. The support Langmuir provided was crucial to the
146 Ibid.
14' Nalin, interview, 14 February 1992, transcript p. 13, and personal correspondence, 26 March 1992.
148 An explanation ofMosley's position at the Cholera Research Laboratory requires some backtracking. When
Phillips joined the laboratory in 1965, he did so on the understanding he would have no involvement with
epidemiology. The National Institutes for Health therefore called Alex Langmuir at the Centers for Disease
Control (CDC) who gave Mosley the appointment of head of epidemiology. Mosley, interview, 25 February
1992, transcript p. 8.
14' Ibid., pp. 6, 7.
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implementation of the protocol, as Mosley explains, he "saw the world-wide impact of
this, but the rest of us still didn't quite appreciate it.150
Langmuir, who communicated with Phillips frequently, says that he never
comprehended just why Phillips did not desire to go ahead with the field trial. He
corroborates Mosley's assertion that Phillips distinguished between the "applied
research", which Nalin and Cash desired, and "basic fundamental research", which
Phillips wanted them to do.'5' Langmuir, however, believes that there might have been
more to Phillips' resistance than this distinction:
Part of this [resistance to the Matlab trial] also was a divided loyalty ... in Dr Phillips
himself because he was the former chiefofthe lab in Taiwan (NAMRU-2), and they were
working on this also. After all, they had been working on it first, before anything was even
discussed in Dacca... and a divided interest is just not the way. He had a definite
continuing loyalty to the work that was being done in Taiwan... and [believed] they
should have the opportunity to do the field test.'52
Langmuir states that Phillips approved the trial, or "at least he didn't stop it".'553 Both
Mosley and Langmuir agree that although Phillips did not want the trial to go ahead in
Dacca, he did not totally impede the process. Nevertheless, Nalin believes that there was
something more to this resistance. He asserts that Phillips had an agreement with John Seal
at the National Institutes for Health, and, at least initially, attempted to block the process.
This interpretation of the situation is not inconsistent with the views of Langmuir and
Mosley; however, they feel that Nalin has exaggerated Phillips' response.154 The
involvement of Seal probably increased Nalin's perception of a threatening atmosphere.
According to Nalin and others, Seal sent a menacing telegram in which he backed up
Phillips (and was apparently inspired by previous communication with Phillips). 55 This
telegram has never been found. Seal claimed that he "cannot recollect such acable, doubts
that he would have used their [threatening] wording" and could not find it in any of his
files.'56 However, there is evidence of correspondence between Seal and Phillips on this
very issue.
On 11 October 1968, Seal, in his capacity as Chairman of the NIH Cholera Advisory
Committee, wrote a letter to Phillips which indicated ongoing discussion on the topic of
the Matlab trial. By this time, Seal wrote, the request for health officers from Langmuir
had already been filed, and Seal expressed some reservations about this after having read
the article by Nalin and others on 'Oral maintenance therapy for cholera in adults'
published in the Lancet. Seal responded very apprehensively to a cautionary sentence in
the report which read, "We would emphasize that the continued need for intravenous
therapy and forcareful records ofintake and output dictate that specially trained staffmust
'5 Ibid., p. 8.
Dr Alexander Langmuir, interview, 28 February 1992, transcript p. 1.
152 Ibid.
-5-3 Ibid.
-54 Ibid., p. 4, and Mosley, interview, 25 February 1992, transcript p. 9.
-5 Cash, op. cit., note 39 above, p. 12.
5' Van Heyningen and Seal, op. cit., note 6 above p. 238.
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supervise the management ofcholera patients who are on oral maintenance therapy". Seal
concluded from this judicious comment that the Matlab trial should be placed on the back
burner and "be reviewed in depth within the laboratory and by the Technical and Clinical
Research Committees before decision".157 Seal desired to block the Matlab field study for
at least a few months.
In conclusion Seal wrote, "It was evident during your [Phillips'] visit that I had
misinterpreted your problem in the earlier letter and now I find myself not knowing
whether you are or are not in favor of the oral therapy trial".'58 Apparently, Phillips had
conveyed some reservations about the project to Seal, but recent developments had
rendered Phillips' opinion ambiguous. Seal therefore intimated that Phillips should convey
what he wanted done with the study so that Seal could rubber stamp it. Whether or not Seal
sent a menacing telegram, he evidently wanted the process halted for the time being,'59
and although his words were not threatening, they were communicated in an official
capacity. Furthermore, had the study gone to committee the epidemic would have passed
and the opportunity to carry it out would have been delayed until the following cholera
season, by which time Nalin would have returned to the United States. His term at the
laboratory had not been renewed.
All the objections and insinuated threats which Phillips made to Cash and Nalin
exhilarated and encouraged them to move ahead. In Nalin's words, "it showed us that
there was a stick somewhere behind the carrot".161 Cash and Nalin, with their Bengali and
U.S. colleagues, chased and reached the carrot at Matlab through the support of Langmuir
and Mosley. Their study confirmed that some cholera patients could be rehydrated with
oral rehydration therapy alone and that field staff could be trained to administer the
therapy with ease.'6' Most significant was their proof that oral rehydration therapy was a
practical treatment which could be used to treat large numbers of patients in primitive
conditions where little intravenous therapy was available.
With the Matlab study complete, ORT had one scientifically supported use: treatment
for adult cholera patients. A host of researchers at the laboratory and in Calcutta
recognized, however, that the potential extended far beyond cholera in adults. Nalin, Cash,
and their colleagues, made the next significant breakthrough: they showed that oral
rehydration solution is "as effective in the non-cholera diarrhoeal patients as in cholera
"' John R. Seal, MD, personal letter to Robert A. Phillips, I I October 1968. Washington, DC.
1.58 Ibid.
15' This incident further discredits the history of ORT presented in Van Heyningen's and Seal's book. The
preface is extremely telling and explains well why the nature of such controversies was not described. In van
Heyningen's section of the preface he writes that he "is grateful, deeply grateful, to his present collaborator,
J.R.S. IJohn R. Seal1, who proposed the writing of this book in the first place, and without whose encyclopaedic
and unfailing support not only would this book never have been written, but mnanv ofthe main events recorded in
it would not have happened." (Emphasis mine). These words highlight the dedication with which this book
presents Seal in the most positive light. Nothing of a critical nature is mentioned, not even the potentially
detrimental relationship between Seal and Phillips. Op. cit., note 6 above, preface.
'i'" Nalin, interview, 14 February 1992, transcript p. 14.
161 Richard A. Cash, David R. Nalin, Roger Rochat, L. Barth Reller, Zahedul A. Haque, and A. S. M. Mizanur
Rahman, 'A clinical trial of oral therapy in a rural cholera-treatment center', Am. J. Trop. Med. Hv,g., 1970, 19
(4): 653-6. Rochat and Reller were the Epidemiological Intelligence Service officers commissioned by
Langmuir.
388Plate I (a): This UPI photograph was taken at Matlab during the 1969 field trial and shows Nalin examining the
pulse ofa patient receiving IV rehydration to correct shock present on admission, prior to starting oral therapy (24
March 1969.) (Courtesy of the Bettmann Archive).
Plate I (b): This photograph, taken during the second protocol in Dacca, pictures the chiefstudy nurse, Bashonti,
starting oral therapy for a patient coming out of shock. Note that the IV, used for rehydration, is still connected.
(Courtesy of Dr David Nalin.)Plates 2 (a) and (b): The "miracle" ofORT. A boy
manifesting signs ofserious dehydration such as lost
skin turgor is treated with ORT and is soon back to
normal. (Courtesy of ICDDR, B; photographs by
Asem Ansari.)Plates 3 (a) anid (b): A girl suffering from
dehydration is given ORT. Below, she is seen after
the treatment. (Courtesy ICDDR, B; photographs by
Asem Ansari.)Plate 4 (a): Bengalis in Matlab mix the ingredients for oral rehydration solution and put them in small plastic
packets for community distribution. (Photograph by the author.)<'^->~~~~~..
Plate 4 (b): The new rice-based oral rehydration solution being administered in Dacca. (Courtesy ofICDDR, B;
photograph by Asem Ansari.)The historv oforal rehydration therapy
patients".'62 In another study, Nalin and Cash and others showed that ORT alone may be
used to treat moderate to severe dehydration.'63 Additionally, they demonstrated the
effective use of ORT in the treatment of children.'64
GAINING MOMENTUM
Perhaps the greatest practical ORT success after Matlab was the Calcutta team's work
demonstrating that ORT could be implemented even under disastrous circumstances. Dilip
Mahalanabis led the challenging work in refugee camps during the Bangladesh War of
Independence.'65 Unlike the Matlab study, in which trained staff charted every patient,
family members were responsible for the administration ofthe oral rehydration solution.'66
Thus the refugee camp work not only proved that ORT could be used in emergency
situations, but it also saved lives that otherwise would have been lost. Moreover, the work
enabled ORT to "really hit the map ... [since] it probably took that kind ofa demonstration
in a crisis to really document what could be done".167 For those doctors such as Langmuir,
who were involved with ORT on a political, behind-the-scenes level, Mahalanabis's work
was crucial: "Cash and Nalin's work is tremendous, and I'm not denigrating that at all, but
the Mahalanabis one turned me on".'68 This comment shows how the Mahalanabis study
differed from that at Matlab where, although the conditions were terrible, the study was
smaller and it was entirely premeditated. Mahalanabis's work was quite simply a response to
an emergency and therefore drew the attention of global health organizations such as the
United Nations Children's Fund and the World Health Organization.
ORT began demonstrating success after success as physicians experimented with it in
different cases of diarrhoea and among patients of all ages. In 1971 and 1972, soon after
the work by Mahalanabis, Hirschhorn returned to ORT research, this time in Arizona.
Under the influence of Bob Gordon, who six years earlier had sent Sachar to the Dacca
laboratory, Hirschhorn worked with Apache children who were suffering from diarrhoea
of various aetiologies (although never cholera).
He found that the treatment then being used for diarrhoea was "old-fashioned" since it
called for intravenous fluids while starving the gut.'69 Cash taught Hirschhorn how to use
'"` David R. Nalin and Richard A. Cash, 'Oral or nasogastric maintenance therapy for diarrhoea of unknown
aetiology resembling cholera', Trains. R. Soc. Trop. Med. HI-g., 1970, 64 (5): 769. It is important to recognize
the distinction between oral rehydration therapy (ORT) and oral rehydration solution (ORS). ORS refers only to
the electrolyte solution itself. ORT encompasses the use of ORS to replace fluid losses and maintain the patient,
as well as the early commencement of nutritious feeding. Thus UNICEF and other organizations label their
packets of salt, glucose, and citrate, "ORS", while championing ORT.
'"- Richard A. Cash, David R. Nalin, et l., 'Rapid correction ofacidosis and dehydration ofcholera with oral
electrolyte and glucose solution', Lincet, 1970, ii: 549-50.
'"4 D. R. Nalin, et atl., 'Oral (or nasogastric) maintenance therapy for cholera patients in all age-groups',
Bull. W.H.O., 1970, 43: 361. Mahalanabis asserts that the Calcutta group also demonstrated the efficacy ofORT
in children between June 1969 and July 1970. Their publication, however, followed much later. D. Mahalanabis,
R. B. Sack, et (il., 'Use of an oral glucose electrolyte solution in the treatment of pediatric cholera-a controlled
study', J. trop. Pedjaitr., 1974, 20: 82-7.
161 Mahalanabis worked from March 1971 to the autumn at the southwest Indian/Bangladeshi border.
'"" Norbert Hirschhorn, 'From bedside to worldwide: the progress oforal rehydration therapy', presentation at
The Charles A. Dana Award For Pioneering Achievement In Health, 8 November 1990, pp. 5-6, 15-24. See also
Dilip Mahalanabis, et (il., 'Oral tluid therapy of cholera among Bangladeshi refugees', John Hopkins m1ed1. J.,
1973, 132: 197-205.
"' Mosley, interview, 25 February 1992, transcript p. 8.
'6 Langmuir, interview, 28 February 1992, transcript p. 2.
69 Hirschhorn, interview, 10 January 1992, transcript p. 7.
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ORT, and they achieved excellent results by implementing early feeding along with the
therapy. Among their findings, they demonstrated that children down to the age of one
month could be treated with oral therapy. Most importantly, their study indicated that
dehydrated children would drink the solution to the point of hydration-they instinctively
knew how much they needed.'70 Within one year, Hirschhorn and others had confirmed
their hunch that ad libitum oral therapy worked.'7' Hirschhorn remarks that this discovery
clearly showed the superiority of ORT over intravenous treatment, where the chance for
error while administering the solution was much greater because intake and output had to
be carefully recorded.'72 ORT eliminated the necessity for that process since the patient
would drink the proper amount.
ORT ENTERS THE U.S.
With his work in a Native American reservation, Hirschhorn brought ORT to the front
locked doors of U.S. clinicians. Whereas the work in Dacca and Calcutta had involved
cholera, an exotic affliction, Hirschhom treated the kind of diarrhoea that was familiar to
American physicians. Moreover, in Dacca ORT had been utilized under primitive
conditions, but in the U.S. Hirschhorn used it in a technologically more advanced
environment. An editorial comment following his ad libitum study stated that "a similar
approach should be evaluated in modern urban settings under equally carefully controlled
conditions". 173 This illustrates the suspicion with which contemporary American
medicine treated ORT, as well as the disbelief that a therapy so simple could out-perform
high technology. One anecdote which Hirschhorn tells demonstrates this type of
conservatism and arrogance, especially among paediatricians:
I had an anthropologist friend who adopted an Apache child from the reservation where we
were working. He used to be the anthropologist on the reservation. And then he went to
Arkansas to teach and the Apache child came down with severe diarrhoea and he called
me up and he said desperately, "Look, my son's in the hospital and they're giving him all
sorts of intravenous fluids. The diarrhoea's not stopping, he's losing weight, they're not
feeding him. I know that you did this work in Arizona and it didn't look like that". And he
said, "Would you call this professor of paediatrics and just collegiately talk to him'?" So I
called up the professor and told him that in our experience with Apache children this is
what we found and here's the publication and so on. And he said to me, "Doctor, doctor,
our children are not the same as your children". He was treating an Apache child from the
same reservation. 174
Clearly some doctors in the medical establishment viewed ORT as a solution for problems
in the developing world, but not in the industrialized nations and, furthermore, they
overlooked the substantial scientific evidence which supported its use. With the work of
170 Norbert Hirschhorn, Richard A. Cash, William E. Woodward, and Gary H. Spivey, 'Oral fluid therapy of
Apache childien with acute infectious diarrhoea', Lancet, 1972, ii: 15-18, on p. 17.
17' Norbert Hirschhorn, Brian J. McCarthy, Bobbette Ranney, Mary Ann Hirschhorn, Susan T. Woodward, Ann
Lacapa, Richard A. Cash, William E. Woodward, 'Ad libitum oral glucose-electrolyte therapy for acute diarrhea
in Apache children', J. Pediatr., 1973, 83 (4): 562-71, on pp. 568-9.
172 Hirschhorn, interview, 10 January 1992, transcript p. 7.
173William B. Weil, Jr. 'Editorial comment', J. Pedjaitr., 1973, 83 (4): 571.
17' Hirschhorn, interview, 10 January 1992, transcript p. 10.
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Crane, Sachar and other physiologists having been published, to deny the validity ofORT
was to deny the findings of a decade of physiological progress.
In addition to ORT being supported by a relatively new physiological paradigm, other
factors may have retarded its acceptance among physicians in the United States. In the
early 1970s, the greatest use of ORT continued to be for cholera outbreaks in developing
countries. UNICEF and the World Health Organization produced large numbers of oral
rehydration solution packets and maintained these supplies at strategic locations around
the world. 175 The association of the therapy with disaster relief and the developing world
may have contributed to the ongoing view in the States that ORT was for other children,
other adults, and other diseases.
The poor coverage of ORT by the U.S. media did not encourage the public or the
medical establishment to recognize swiftly its efficacy. In the New York Times, for
instance, coverage of cholera epidemics throughout the world consistently overlooked
ORT. In a 1971 article entitled 'Cholera now spreading to remote regions', the author
wrote that "modern methods for delivery of fluids directly into the bloodstream has made
it possible to save victims seemingly on the point of death".'76 ORT was not even
mentioned; an omission which is all the more conspicuous since the article refers to
"remote regions" where intravenous therapy would have been difficult to implement.177
An abundance of articles conveys similar ignorance. Ironically, another in 1971 covered
the issue of dehydration brought on by boiled milk, but failed to mention ORT. Milk
becomes more concentrated when boiled and tums into a hyperconcentrated solution of
non-absorbable substrates which draws water out of a baby's body through the gut. The
central point of the article was the fact that many doctors still prescribed boiled milk for
babies with diarrhoea, thereby only exacerbating the disorder and furthering dehydration.
Contrary to expectations, the doctor interviewed did not suggest ORT as an altemative,
rather, he prescribed, "fruit juices, clear beverages, Jello-water, cola or other nonchilled
carbonated beverage[sI".178 While these could be more effective than the milk, they are
not comparable to a glucose-sodium solution. Articles like these reflect the minimal
impact that ORT had had on medicine and the media in the U.S.
THE INTERNATIONALIZATION OF THE CHOLERA RESEARCH LABORATORY
The type of neglect which ORT received in the U.S. media contrasts sharply with its
rapid implementation elsewhere. Scientific support for the use of ORT worldwide had
17 Ibid., p. 6.
71 'Cholera now spreading to remote regions', New York Times, 26 September 1971, p. 77. See also 'Cholera
clinic in Dacca periled by cutoff in funds', Newt York Times, 28 May 1972, p. 2. Lawrence K. Altman, 'Health
agency, expecting cholera to spread, begins to train doctors in black Africa', New York Tinmes, 8 September 1970,
p. 10. The Newt York Timties first reported the discovery of "a salty drink" (ORS) for the treatment of cholera in
1970: Lawrence K. Altman, 'Simple cholera treatment, a salty drink, developed', 28 September 1970, p. 9. In
this newspaper, the article remains unique for its exclusive discussion of the effectiveness of ORT. Through the
1970s writers for the Nevw York Times either omitted ORT or mentioned it only in passing. In 1983, however, the
editors advocated ORT along with other child survival techniques that UNICEF had recently publicized. See 'All
God's children', Newt York Times, 31 December 1983, p. 22.
177 Other popular periodicals such as Time and Newissweek ignored ORT and published no more than six articles
on the subject between 1960 and 1980.
1'7 Jane Brody, 'Boiled milk a peril for diarrheic baby'. New York Timtes, 4 July 1971, p. 29.
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reached the press by 1971, with the completion of the work by Mahalanabis and
Hirschhorn. Within six years there was a tangible global plan for the promotion and
utilization of ORT. It seems supremely ironic that just as ORT began its journey toward
universal usage, the Cholera Research Laboratory where the therapy had first proved
effective faced severe difficulties. By 1976, decreased international interest and the
secession of East Pakistan (and the establishment of Bangladesh) had placed the Cholera
Research Laboratory in a dire financial condition. At that time, Greenough, Mosley, and
others set out to internationalize and expand the laboratory.'79 Greenough states that the
major difficulties which it faced grew out ofthe lack of"any political commitment or any
support, other than for scientific projects, to implement any of the knowledge that had
been gained up to that point".'8" Despite the obstacles, ORT managed to achieve
worldwide notoriety and acceptance in record time.
In 1979, the Cholera Research Laboratory was officially designated the International
Centre for Diarrhoeal Disease Research, Bangladesh. No longer was cholera the primary
target for rehydration research. The World Health Organization recognized that "In
non-epidemic seasons... [cholera] accounts for less than 5% to 10% of all acute
diarrhoeas in cholera endemic areas".181 The Advisory Group for the World Health
Organization's diarrhoeal disease programme met in Geneva in May 1978 and studied a
number of tactics which could be used in the fight against such diseases. For many of the
vaccine and drug programmes there was insufficient information orjustification for their
implementation. However, the Group concluded that "oral rehydration therapy was a
strategy that could be put into effect now with the available means and have an immediate
and far-reaching impact".'82 The Advisory Group created a global oral rehydration
programme seven years after sufficient evidence for the efficacy of ORT had been
published.'83
THE 0 IN ORT
For a discussion about the development of ORT to have any significance an explicit
examination of what is meant by oral rehydration therapy is required. For example, the
misleading contention that Hirschhorn and Pierce's work in 1966 constituted oral therapy
appears in a variety offorums, from conferences to medicaljournals. To suggest that they
used an oral solution implies that although theirs was given intragastrically (and
multi-luminally in the case of Hirschhorn), it was virtually a practical therapy. The
scientific record contests this conclusion. Although their work made use of a solution
similar in composition to Nalin's, they were carrying out metabolic studies. The
instrumentation which they used was too bulky to be practical. Hirschhorn himself
maintains that after his work in Dacca and his departure from the Cholera Research
17' Greenough, interview, 10 January 1992, transcript pp. 5-6.
° Ibid.
'8' 'Control of diarrhoeal diseases: WHO's programme takes shape', op. cit., note 7 above, p. 369.
1x2 Ibid., p. 372.
'13 The story ofORTafter 1968remains mostly unexplored, perhaps because manyofthe people most interested
in it (and able to write about it) are engaged in a fierce battle for its acceptance. I attempted to piece together
some ofthe politicking which succeeded the studies of Mahalanabis and Hirschhorn in the early 1970s but found
that it deserves an essay of its own.
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Laboratory, he "was not optimistic that ORT was feasible as a routine treatment. That task
was left to David Nalin and Richard Cash".184 Hirschhom's comment evokes the image of
a runner handing over the baton to another and implies that his work smoothly progressed
to Nalin's and Cash's breakthrough. This view ofthe development ofORT-that it was a
scientific progression-provides two frameworks for interpreting the discovery. The first
examines it as the culmination of decades of research, while the second suggests that ORT
may have been "discovered" soon after early glucose-sodium absorption research.
THE ROAD TO ORT
If the development of ORT were a simple progression, the treatment might have
culminated from work begun as early as 1832 when Thomas Latta used a saline solution
intravenously to treat cholera.'85 Despite some encouraging results, he did not further his
research. His work may, however, be considered as the beginning of the intravenous
therapy that Leonard Rogers advanced and Phillips virtually perfected in the late 1950s.186
Nevertheless, reconstructing the discovery of ORT over a century stretches the limits of
definitively identifying a scientific progression.
While the 1 830s may seem too distant to establish linearity, the transport work
completed in the 1950s seems to signify a point of departure, albeit a minor one, for
findings that resulted in ORT in 1968. One could credibly argue than any one of the major
physiological breakthroughs beginning with Darrow's denotes the start of the
development of ORT. Although the discovery of ORT itself was not directly dependent on
the physiological studies of the 1940s and 1950s, these, especially glucose-sodium
co-transport theory, provided essential proof for the theoretical utility of ORT since,
according to Hirschhom, "empirical findings were probably not enough to solidify a
therapy".'87 In other words, even if someone had stumbled onto the correct mixture for
oral therapy, it would not have been accepted without supportive physiological paradigms
because so much evidence against oral therapy had accumulated.
Despite the appearance of a single progression in the development of ORT, in retrospect
one can in fact differentiate two distinct lines of scientific work leading to the discovery.
The first, the development of co-transport theory, began with Crane, Riklis, and Quastel in
the 1950s, and peaked with Schultz and Curran in the mid-1960s. The second, the
execution of numerous metabolic studies, began with the serendipitous observations of
Phillips in the Philippines. Sachar's work evolved from Phillips' poisoned sodium pump,
and Hirschhorn executed his experiment because of Sachar's work and Phillips' study.
These two physiological developments were confirmed in Phillips' work since he
demonstrated that the molecular connection between sodium and glucose worked in vivo.
The view of the scientific establishment on the discovery and development of ORT
overlooks the practical work in Dacca and Calcutta and reserves its ultimate praise for the
IX Hirschhorn, op. cit., note 166 above, p. 18.
185 Norbert Hirschhorn, 'The treatment of acute diarrhea in children: an historical and physiological
perspective', Am. J. Cliii. Nitr., 1980, 33: 637-63, on pp. 637-8.
"' See Raymond H. Watten and Robert A. Phillips, 'Potassium in the treatment of cholera', Lancet, 1960, ii:
999-1(X)1.
IX7 Hirschhorn, interview, It) January 1992, transcript p. 1. Hirschhorn credits Nalin and Cash with having
worked out the practical application for ORT. As to the question of who discovered ORT, Hirschhorn believes
that it was "all a mosaic".
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most theoretical studies. This attitude was well represented by the Lancet when the editors
declared that "The discovery that sodium transport and glucose transport are coupled in
the small intestine, so that glucose accelerates absorption of solute and water, was
potentially the most important medical advance this century'88 This judgement implies
that the findings of Crane, Schultz and Curran were the direct predecessors of ORT-a
conclusion that ignores crucial metabolic studies and Nalin's brilliant leap to a practical
regimen.'89 The co-transport research was crucial primarily because the researchers who
developed ORT could point to it for support. The statement in the Lancet reflects the
temptation for historians and scientists to reduce scientific discoveries to a line of
theoretical breakthroughs that appear to flow smoothly into practical applications. ORT is
an example ofthe difficult path that may lead to a discovery-from Phillips' extraordinary
observation to a simple solution any parent can administer to a sick child.
THE POTENTIAL FOR ORT BEFORE 1968
Given the extremely simple composition of ORT, one might expect that an examination
of the medical literature would reveal previous, successful oral therapy experiments. Only
one comes to light that not only was independent of many important physiological studies,
but preceded them. In 1953, Hemendra Nath Chatterjee, an Indian doctor working on
cholera in Calcutta, managed to rehydrate patients with "mild to moderately severe
cholera ... without intravenous or parenteral transfusions" and published his findings in
the Lancet.'90 He treated 186 patients with an oral glucose-sodium electrolyte solution that
closely resembled the one employed by Nalin fifteen years later, and there were no
fatalities. However, Chatterjee's work failed to provide controls and net fluid balance
sheets, scientific tools that might have fostered credibility;'9' and his use ofexotic Indian
plants to halt vomiting and diarrhoea, as well as his administration of some rehydration
therapy by enema may have struck the readership of the Lancet as being too foreign and
unscientific. Whatever the case, his article failed to stimulate follow-up studies. It is
generally agreed that racism or the lack of a "scientific" rationale prevented the
widespread adoption of his work.'92
While Chatterjee's study did not present or cite a supportive physiological paradigm
and could therefore be branded as a fluke, one might question whether a doctorcould have
extrapolated an effective oral therapy from early glucose-sodium co-transport studies. The
experience of Qais Al-Awqati, an Iraqi physician, implies that this was in fact possible.
In 1966 a cholera epidemic erupted in Baghdad where Al-Awqati was doing his medical
residency. Although he lacked scientific training and was unaware of the research in
Calcutta and Dacca, Al-Awqati had studied the physiological experiments of Crane and,
decided to try an oral electrolyte solution based on them. During the six weeks of the
"'X 'Water with sugar and salt', editorial, Lancet, 1978, ii: 300.
189 Interestingly, Schultz contends that thediscovery "was largely a matterofan idea whose time hadcome". By
1968, Schultz would argue, there was such an accumulation ofscientific evidence fora practical oral therapy that
the development of a regimen was destined to occur. Schultz, interview, 24 February 1992, transcript p. 2.
19" Hemendra Nath Chatterjee, 'Control ofvomiting in cholera andoral replacement offluid', Lancet, 1953, ii:
1063.
"9' Cash, op. cit., note 39 above, p. 10.
192 Schultz, interview, 24 February 1992, transcript p. 6. Nalin, interview, 14 February 1992, transcript p. 16.
Field, interview, 19 February 1992, transcript p. 4.
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epidemic, he successfully treated the majority of his 500 patients with an imprecisely
measured glucose-sodium solution. This allowed the doctors to reserve the intravenous
treatment exclusively forpatients in shock. The experience inspired Al-Awqati to continue
work on the topic since "there is nothing more impressive than seeing somebody down to
zero blood pressure, somebody at death's door, and they [have a little intravenous therapy
and a lot of oral rehydration therapy] and can leave the hospital in a few days".'93
The experiences ofAl-Awqati in Iraq and Chatterjee in Calcutta highlight how difficult
a discussion of the date and circumstances of the "discovery" of ORT can be. Both men
successfully used an oral solution but today receive no credit for their efforts and
observations. Likewise, there may have been many other people who did similar work but
never published. Clearly, for ORT to be an integral component of a global health
programme a few carefully monitored clinical trials based on an accepted physiological
paradigm were needed. Thus Nalin and Cash were the first to demonstrate oral therapy as a
practical therapeutic alternative to parenteral therapy in April 1968. However, their work
did not occur in a vacuum; a myriad of other tindings were essential for a supportive
physiological paradigm.
Al-Awqati's experience demonstrates that physiological research could have provided
an essential framework for developing an oral therapy.'94 But in the 1950s, the
physiological paradigm under which Western physicians operated was that intravenous
therapy was superior to all others. Thus, a researcher who read the study by Chatterjee
might have thought that the concept was interesting but that Western medicine had
surpassed any simplistic (and therefore inferior) solutions to cholera. Intravenous therapy
appeared more scientific, there was an apparatus, and the physician could have precise
control over the intake of a patient. Oral therapy appeared primitive and less controlled.
Thus, Chatterjee may have failed to inspire additional researchers because they had a
psychological block which impaired their ability to consider or replicate his results.
ORT might also have been developed long before 1968 but for the attitudes of the
dominant medical establishment toward practical experimentation, which the Cholera
Research Laboratory and the National Institutes for Health shared. Nalin believes that "the
people at the lab ... got kudos for the extent to which [their] work was not practical. As
soon as it became practical it was discarded like a soiled towel-it was too common, too
hands-on... so the prestige went to people who measured trans-intestinal fluxes or
electrical currents". 95 Phillips, who wanted nothing to do with practical applications, no
doubt profoundly influenced Nalin's perspective. However, he was a talented researcher
and a better rounded scientist than these incidents reveal. His methodology for
experimentation was to test a brilliant idea on a very small scale; if the results were
positive, he would then continue. This framework clashed with the desire of Nalin and
1"3 Qais Al-Awqati, interview, 19 February 1992, transcript p. 2. See also Qais S. Al-Awqati, Mehdi Mekkiya,
and Mahmud Thamer, 'Establishment of a cholera treatment unit under epidemic conditions in a developing
country', Lincet, 1969, i: 252. This article was written only after Al-Awqati arrived in the United States and
was encouraged by Dr Greenough. The editors of the Lancet rewrote the article and hardly mentioned that the
doctors had used oral therapy, concentrating instead on the public health perspective of the story.
"' Nalin discourages this notion and states that the paradigm that there is "a logical progression from basic
science to applied science lisl a fiction lin this instancel". Nalin, interview, 14 February 1992, transcript p. 17.
1'5 Ibid., p. 15.
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Cash to conduct large scale practical experimentation. Nalin states accordingly that
Phillips "was the essence ofthe creative scientist whereas he reported to Seal [and the NIH
as] the essence of the Bethesda bureaucrat".'96
Although Phillips, the symbol of conservative medical approach in Dacca, influenced
Nalin and Cash, they were sufficiently free from the dogma of the medical establishment
to design and execute their own work. Hirschhorn and Pierce believe that one trait shared
by nearly all the oral rehydration investigators was that, ironically, they had no training or
experience in paediatric medicine.'97 They were working towards a therapy that would
benefit children, but they had not been indoctrinated by the paediatric medical
establishment which embraced intravenous therapy and opposed oral therapy.
ORT, even in the light of co-transport theory, had to break through conceptual barriers
in order to gain acceptance. Most investigators could not imagine patients swallowing and
holding down the amount of fluid required for an oral therapy regimen. Nalin and Cash
shattered this mental block with the second protocol demonstrating that the contrary was
true. Since this work convinced only themselves and their immediate peers, I believe that
it is appropriate to refer to their experiment in Dacca formally as the "discovery" of oral
therapy. Their initial work, however, did not account for the global implementation of
ORT programmes. Without the crucial diffusion that Mahalanabis and others inspired,
ORT would have remained a discovery of far less importance.'98
The amount of time needed for the U.S. medical establishment to accept ORT dwarfs
the seven years that passed before the major public health institutions of the world
embarked on a global ORT programme. In 1992 a small group of researchers met in
Atlanta, Georgia, under the auspices ofthe Centers for Disease Control (CDC) to discuss a
plan to benefit American children by promoting the therapy. The CDC had called the
meeting in order to make a public statement on the value of ORT in the U.S.'99
Organizations have been formed in the States to promote its use in hospitals and homes.2""
Their existence testifies to the conservatism of a medical establishment, an identical
attitude to that which slowed the development of ORT in the first place.21)' This need to
promote oral rehydration demonstrates that a superior therapy, even when supported by an
ironclad physiological paradigm, may not necessarily be employed.
The formidable and persistent ignorance of the Western medical establishment, which
continues over twenty-five years after the discovery of ORT, is phenomenal. While its
'96 Ibid., p. 16.
"9' Hirschhorn, interview, 10January 1992, transcript p. 2, and Pierce, interview, 31 March 1992, transcript p. 3.
"' For a substantive description ofthe terms innovation and discovery, seeJohn V. Pickstone, 'Introduction', in
John V. Pickstone (ed.), Medical innotiltions in historical perspective, New York, St Martin's Press, 1992,
pp. 1-16.
199 Roger 1. Glass, personal letter to Dr David Nalin, 3 March 1992. This meeting and subsequent research led to
a Morbiditv antd mortality wteekls report devoted to ORT. See Christopher Duggan, Mathuram Santosham, and
Roger 1. Glass, 'The management of acute diarrhea in children: oral rehydration, maintenance, and nutritional
therapy', MMWR, 16 October 1992, 41.
2100 For example, The National ORT Project in Washington, DC.
2011 Oral rehydration development continues today. In the late 1970s researchers developed a cereal-based oral
rehydration therapy which rehydrates the victim and decreases the quantity of stool. Today, at the cholera
research hospital where Cash and Nalin first tested an oral therapy, rice-based ORS is the solution of choice.
Although cereal-based oral solution has been hailed by some as superior to the original, there is no decisive
evidence to this effect.
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refusal to advocate ORT may be due in part to the notion that ORT is only necessary for
people in the developing world, its actions appear to be driven also by financial
considerations. Most hospitals do not train physicians in the use ofORT since they have no
financial reason to do so.202 The use of intravenous therapy, which often involves keeping
a dehydrated child overnight, assures maximum insurance reimbursement. Sending
children home with ORT would destroy these profits. Furthermore, recent studies show
that diarrhoeal illness among the elderly may incur even greater health care costs that
could also be reduced by the use of ORT.203 At a time of heated discussion about
cost-containment in health care, it seems all the more ironic and egregious that a superior,
cheap, and proven therapy continues to be superseded by a far more expensive one.
Estimates based on the cost of hospitalizations and physician visits suggest that ORT
could save billions of dollars annually.204 The dominant attitude toward ORT in the U.S.
demonstrates that the medical powers that be need a new operational paradigm, one that
grants credit to those who develop practical therapies as well as to those who use them.205
In contrast to the U.S., the developing world uses Oral Rehydration Therapy
extensively. In addition to saving millions of lives there, its use should draw more
attention to the poor water supplies and unsanitary living conditions that create such an
immense need for the therapy. ORT is not a solution to the global epidemic ofdiarrhoea: it
is only a treatment that prevents diarrhoeal deaths. ORT can buy time for nations and
international development organizations to marshal their resources for clean water,
sanitation, and other projects that constitute long-term solutions to diarrhoeal disease.
2-2 Greenough, personal communication, April 1994.
203 Ofthe 28,538 diarrhoeal deaths in the U.S. between 1979 and 1987, 51 per cent occurred in adults over the
age of 74. Richard G. Bennett and William B. Greenough III, 'Approach to acute diarrhea in the elderly',
Gastroenterology Clinics ofNorth America, 1993, 22 (3): 517-33, on pp. 517, 530, and William B. Greenough
111, personal communication, April 1994.
204 Recent studies indicate that 16.5 million children in the U.S. under the age offive have between 21 and 37
million episodes of diarrhoea annually. Roughly 3 million of these episodes lead to a visit with a physician and
220,()00 are hospitalized. Eighty per cent of these hospitalizations could likely be avoided by ORT use.
Approximately 400 children die annually frotn diarrhoeal illness in the U.S. See Roger 1. Glass, et al., 'Estimates
of morbidity and mortality rates for diarrheal diseases in American children', J. Pedillr., 1991, 118 (4): 27-33,
on pp. 27, 32, and Roger 1. Glass, personal communication, April 1994. Also David Nalin, personal
communication, April 1994 and Greenough, personal communication, April 1994.
05 The CDC, among other organizations, has already accomplished relevant work. In its MMWR devoted to
ORT, the authors encouragingly concluded that "When the principles of loral and nutritional] therapy that are
outlined lin this publication are accepted by all levels of the U.S. medical community, and when education of
parents includes instructions about how to begini ORT at home, then unnecessary hospitalizations and deaths can
be prevented". Duggan, et ol., op. cit., note 199 above, p. 16.
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